Tokushima University / Educator and Researcher Directory --- Morigaki, Ryoma

Field of Study

○	Neurosurgery

Subject of Study

○	機能的脳神経外科

Book / Paper

Book:

1.	Toshitaka Kawarai, Ryoma Morigaki, Oki Ryosuke, Satoshi Goto and Ryuji Kaji : ALS and TFG, 科学評論社, Apr. 2015. (Keyword) TRK-fused gene (TFG) / amyotrophic lateral sclerosis / hereditary sensory motor neuropathy with proximal dominant involvement / vesicular transport / TDP-43
2.	Ryoma Morigaki and Satoshi Goto : Deep brain stimulation for essential tremor, Springer, Switzerland, 2015. (Link to Publication Site) ● Publication site (DOI): 10.1007/978-3-319-08476-3_11 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.1007/978-3-319-08476-3_11 (DOI: 10.1007/978-3-319-08476-3_11)
3.	Ryoma Morigaki and Ryuji Kaji : Movement Disordersの内科的治療, Dec. 2013.
4.	Ryuji Kaji, Koutaro Asanuma, Toshitaka Kawarai, Yoshimichi Miyazaki, Ryoma Morigaki, Satoshi Goto, 目崎高広, 太田悦朗, 小幡文弥, 豊島至, 藤本健一, 野村哲志, 中島健二, Takashi Sakamoto, Kenta Sato, 平孝臣, 横地房子, 小林一太, 片山容一, 小林武夫, 石毛美代子, 松本英之, 宇川義一, 玉川聡, 辻貞俊, 堀内正浩 and 長谷川一子 : ジストニアのすべて―最新の治療指針, 株式会社診断と治療社, Tokyo, May 2013.
5.	Ryoma Morigaki : 重症度評価ーBurke-Fhan-Marsden ジストニア評価スケール, May 2013.
6.	Ryoma Morigaki, Ryuji Kaji, Shinji Nagahiro and Satoshi Goto : Thalamic deep brain stimulation for Parkinsons disease., 2011.
7.	Ryoma Morigaki, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : Current use of thalamic surgeries or treating movement disorders, 2011.

Academic Paper (Judged Full Paper):

1.	Joji Fujikawa, Ryoma Morigaki, Kazuhisa Miyake, Taku Matsuda, Hiroshi Koyama, Teruo Oda, Nobuaki Yamamoto, Yuishin Izumi, Hideo Mure, Satoshi Goto and Yasushi Takagi : Cranial geometry in patients with dystonia and Parkinson's disease., Scientific Reports, Vol.13, No.1, 2023. (Summary) Abnormal skull shape has been reported in brain disorders. However, no studies have investigated cranial geometry in neurodegenerative disorders. This study aimed to evaluate the cranial geometry of patients with dystonia or Parkinson's disease (PD). Cranial computed tomography images of 36 patients each with idiopathic dystonia (IDYS), PD, and chronic subdural hematoma (CSDH) were analyzed. Those with IDYS had a significantly higher occipital index (OI) than those with CSDH (p = 0.014). When cephalic index (CI) was divided into the normal and abnormal groups, there was a significant difference between those with IDYS and CSDH (p = 0.000, α = 0.017) and between PD and CSDH (p = 0.031, α = 0.033). The age of onset was significantly correlated with the CI of IDYS (τ = - 0.282, p = 0.016). The Burke-Fahn-Marsden Dystonia Rating Scale motor score (BFMDRS-M) showed a significant correlation with OI in IDYS (τ = 0.372, p = 0.002). The cranial geometry of patients with IDYS was significantly different from that of patients with CSDH. There was a significant correlation between age of onset and CI, as well as between BFMDRS-M and OI, suggesting that short heads in the growth phase and skull balance might be related to the genesis of dystonia and its effect on motor symptoms. (Keyword) Humans / Dystonia / Parkinson Disease / Treatment Outcome / Deep Brain Stimulation / Dystonic Disorders / Skull / Hematoma, Subdural, Chronic / Globus Pallidus (Tokushima University Institutional Repository) ● Metadata: 118394 (Link to Publication Site) ● Publication site (DOI): 10.1038/s41598-023-37833-3 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37420081 ● Search Scopus @ Elsevier (PMID): 37420081 ● Search Scopus @ Elsevier (DOI): 10.1038/s41598-023-37833-3 (Tokushima University Institutional Repository: 118394, DOI: 10.1038/s41598-023-37833-3, PubMed: 37420081)
2.	Nobuaki Yamamoto, Kazutaka Kuroda, Yuki Yamamoto, Izumi Yamaguchi, Shu Sogabe, Kenji Shimada, Ryoma Morigaki, Yasuhisa Kanematsu, Yuishin Izumi and Yasushi Takagi : Long-sheath Introducer-assisted Revascularization (L-SHARE) Technique for Treating Large-vessel Occlusion by a Giant Clot, Internal Medicine, Vol.62, No.6, 909-913, 2023. (Summary) Revascularization for common carotid artery (CCA) occlusion might be difficult. We reported our strategy for revascularizing CCA occlusion by giant clots. A 94-year-old woman was transferred to our hospital because of right hemiparesis and aphasia. CCA occlusion and giant clots were detected on ultrasonography. We performed mechanical thrombectomy using a 9-Fr balloon-guiding catheter, stent retriever, and aspiration catheter through a 9-Fr long-sheath introducer [long-sheath introducer-assisted revascularization (L-SHARE) technique]. We successfully recanalized CCA occlusion using this method. The L-SHARE technique might be useful for recanalization of CCA occlusion. (Keyword) mechanical thrombectomy / long-sheath introducer / giant clot / cerebral large-vessel occlusion (Tokushima University Institutional Repository) ● Metadata: 118794 (Link to Publication Site) ● Publication site (DOI): 10.2169/internalmedicine.0089-22 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35945008 ● CiNii @ National Institute of Informatics (CRID): 1390576900004177024 ● Search Scopus @ Elsevier (PMID): 35945008 ● Search Scopus @ Elsevier (DOI): 10.2169/internalmedicine.0089-22 (Tokushima University Institutional Repository: 118794, DOI: 10.2169/internalmedicine.0089-22, PubMed: 35945008, CiNii: 1390576900004177024)
3.	Taku Matsuda, Ryoma Morigaki, Yuki Matsumoto, Hideo Mure, Kazuhisa Miyake, Masahito Nakataki, Masafumi Harada and Yasushi Takagi : Obsessivecompulsive symptoms are negatively correlated with motor severity in patients with generalized dystonia, Scientific Reports, Vol.12, No.1, 20350, 2022. (Summary) We aimed to clarify the correlations between motor symptoms and obsessive-compulsive symptoms and between the volumes of basal ganglia components and obsessive-compulsive symptoms. We retrospectively included 14 patients with medically intractable, moderate and severe generalized dystonia. The Burke-Fahn-Marsden Dystonia Rating Scale and Maudsley Obsessional Compulsive Inventory were used to evaluate the severity of dystonia and obsessive-compulsive symptoms, respectively. Patients with generalized dystonia were divided into two groups; patients whose Maudsley Obsessional Compulsive Inventory score was lower than 13 (Group 1) and 13 or more (Group 2). Additionally, the total Maudsley Obsessional Compulsive Inventory scores in patients with dystonia were significantly higher than normal volunteers' scores (p = 0.025). Unexpectedly, Group 2 (high Maudsley Obsessional Compulsive Inventory scores) showed milder motor symptoms than Group 1 (low Maudsley Obsessional Compulsive Inventory scores) (p = 0.016). "Checking" rituals had a strong and significant negative correlation with the Burke-Fahn-Marsden Dystonia Rating Scale (ϱ = - 0.71, p = 0.024) and a strong positive correlation with the volumes of both sides of the nucleus accumbens (right: ϱ = 0.72, p = 0.023; left: ϱ = 0.70, p = 0.034). Our results may provide insights into the pathogenesis of obsessive-compulsive disorder and dystonia. (Keyword) Humans / Dystonia / Retrospective Studies / Dystonic Disorders / Heredodegenerative Disorders, Nervous System (Link to Publication Site) ● Publication site (DOI): 10.1038/s41598-022-24826-x (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36437372 ● Search Scopus @ Elsevier (PMID): 36437372 ● Search Scopus @ Elsevier (DOI): 10.1038/s41598-022-24826-x (DOI: 10.1038/s41598-022-24826-x, PubMed: 36437372)
4.	J Fujikawa, Ryoma Morigaki, Nobuaki Yamamoto, H Nakanishi, T Oda, Yuishin Izumi and Yasushi Takagi : Diagnosis and Treatment of Tremor in Parkinson's Disease Using Mechanical Devices, Life, Vol.13, No.1, 78, 2022. (Summary) Parkinsonian tremors are sometimes confused with essential tremors or other conditions. Recently, researchers conducted several studies on tremor evaluation using wearable sensors and devices, which may support accurate diagnosis. Mechanical devices are also commonly used to treat tremors and have been actively researched and developed. Here, we aimed to review recent progress and the efficacy of the devices related to Parkinsonian tremors. The PubMed and Scopus databases were searched for articles. We searched for "Parkinson disease" and "tremor" and "device". Eighty-six articles were selected by our systematic approach. Many studies demonstrated that the diagnosis and evaluation of tremors in patients with PD can be done accurately by machine learning algorithms. Mechanical devices for tremor suppression include deep brain stimulation (DBS), electrical muscle stimulation, and orthosis. In recent years, adaptive DBS and optimization of stimulation parameters have been studied to further improve treatment efficacy. Due to developments using state-of-the-art techniques, effectiveness in diagnosing and evaluating tremor and suppressing it using these devices is satisfactorily high in many studies. However, other than DBS, no devices are in practical use. To acquire high-level evidence, large-scale studies and randomized controlled trials are needed for these devices. (Tokushima University Institutional Repository) ● Metadata: 118913 (Link to Publication Site) ● Publication site (DOI): 10.3390/life13010078 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36676025 ● Search Scopus @ Elsevier (PMID): 36676025 ● Search Scopus @ Elsevier (DOI): 10.3390/life13010078 (Tokushima University Institutional Repository: 118913, DOI: 10.3390/life13010078, PubMed: 36676025)
5.	Joji Fujikawa, Ryoma Morigaki, Nobuaki Yamamoto, Teruo Oda, Hiroshi Nakanishi, Yuishin Izumi and Yasushi Takagi : Therapeutic Devices for Motor Symptoms in Parkinson's Disease: Current Progress and a Systematic Review of Recent Randomized Controlled Trials., Frontiers in Aging Neuroscience, Vol.14, 2022. (Summary) Invasive and non-invasive medical devices have unique characteristics, and several RCTs have been conducted for each device. Invasive devices are more effective, while non-invasive devices are less effective and have lower hurdles and risks. It is important to understand the characteristics of each device and capitalize on these. (Tokushima University Institutional Repository) ● Metadata: 117340 (Link to Publication Site) ● Publication site (DOI): 10.3389/fnagi.2022.807909 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35462692 ● Search Scopus @ Elsevier (PMID): 35462692 ● Search Scopus @ Elsevier (DOI): 10.3389/fnagi.2022.807909 (Tokushima University Institutional Repository: 117340, DOI: 10.3389/fnagi.2022.807909, PubMed: 35462692)
6.	Ryoma Morigaki, Ryosuke Miyamoto, Taku Matsuda, Kazuhisa Miyake, Nobuaki Yamamoto and Yasushi Takagi : Dystonia and cerebellum: From bench to bedside, Life, Vol.11, No.8, 776, 2021. (Tokushima University Institutional Repository) ● Metadata: 116560 (Link to Publication Site) ● Publication site (DOI): 10.3390/life11080776 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.3390/life11080776 (Tokushima University Institutional Repository: 116560, DOI: 10.3390/life11080776)
7.	Nobuaki Yamamoto, Yuki Yamamoto, Izumi Yamaguchi, Shu Sogabe, Takeshi Miyamoto, Kenji Shimada, Yasuhisa Kanematsu, Ryoma Morigaki, Yuishin Izumi and Yasushi Takagi : Percutaneous Transluminal Angioplasty and Stenting Using an Aspiration Catheter, Journal of Neuroendovascular Therapy, Vol.16, No.5, 277-282, 2021. (Summary) <p><b>Objective</b>: During percutaneous transluminal angioplasty (PTA) for the vertebral artery, occlusion of the subclavian artery using a balloon guiding catheter may be useful to prevent embolism of clots and/or debris distal to an atherosclerotic lesion. However, when placing a balloon guiding catheter at the intended vessels is difficult, it may be useful to use an aspiration catheter (AC) for mechanical thrombectomy as an intermediate catheter to suction way clots and/or debris. We report two cases in which PTA was performed for an atherosclerotic lesion at the intracranial vertebral artery using an AC, which ended without complications.</p><p><b>Case Presentations</b>: Case 1: A 74-year-old man presented with dysarthria and was admitted to our hospital. MRI revealed severe left vertebral artery stenosis and diffuse cerebral infarct areas at the territory of the posterior circulation. The patient had an abdominal aortic aneurysm and abnormally shaped left tortuous subclavian artery. Therefore, we performed PTA and stenting via the left brachial artery. We guided a 6-Fr long sheath to the left subclavian artery, and a 6-Fr AC for thrombectomy was guided through the long sheath to the V4 portion of the left vertebral artery. Thereafter, PTA was carried out under manual aspiration from the AC. As restenosis at the atherosclerotic lesion occurred after PTA, we performed stenting using a coronary stent system for this lesion under manual aspiration from the AC. No new infarct areas were observed on post-procedural MRI. Case 2: A 74-year-old woman presented with dysarthria and was admitted to our hospital. MRI demonstrated basilar artery occlusion and diffuse cerebral infarct areas at the territory of the posterior circulation. As her symptom worsened after admission, we performed urgent mechanical thrombectomy. We first performed thrombectomy using a stent retriever and then performed PTA and stenting (PTAS) for residual basilar artery stenosis via the AC under manual aspiration.</p><p><b>Conclusion</b>: When it is difficult to place a guiding catheter at the intended vessels during PTA, an AC may be useful to prevent distal embolization.</p> (Keyword) percutaneous transluminal angioplasty / aspiration catheter (Link to Publication Site) ● Publication site (DOI): 10.5797/jnet.cr.2021-0030 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390573593425698304 ● Search Scopus @ Elsevier (DOI): 10.5797/jnet.cr.2021-0030 (DOI: 10.5797/jnet.cr.2021-0030, CiNii: 1390573593425698304)
8.	Hiroshi Koyama, Hideo Mure, Ryoma Morigaki, Ryosuke Miyamoto, Kazuhisa Miyake, Taku Matsuda, Koji Fujita, Yuishin Izumi, Ryuji Kaji, Satoshi Goto and Yasushi Takagi : Long-Term Follow-Up of 12 Patients Treated with Bilateral Pallidal Stimulation for Tardive Dystonia, Life, Vol.11, No.6, 477, 2021. (Summary) Tardive dystonia (TD) is a side effect of prolonged dopamine receptor antagonist intake. TD can be a chronic disabling movement disorder despite medical treatment. We previously demonstrated successful outcomes in six patients with TD using deep brain stimulation (DBS); however, more patients are needed to better understand the efficacy of DBS for treating TD. We assessed the outcomes of 12 patients with TD who underwent globus pallidus internus (GPi) DBS by extending the follow-up period of previously reported patients and enrolling six additional patients. All patients were refractory to pharmacotherapy and were referred for surgical intervention by movement disorder neurologists. In all patients, DBS electrodes were implanted bilaterally within the GPi under general anesthesia. The mean ages at TD onset and surgery were 39.2 ± 12.3 years and 44.6 ± 12.3 years, respectively. The Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) performed the preoperative and postoperative evaluations. The average BFMDRS improvement rate at 1 month postoperatively was 75.6 ± 27.6% ( < 0.001). Ten patients were assessed in the long term (78.0 ± 50.4 months after surgery), and the long-term BFMDRS improvement was 78.0 ± 20.4%. Two patients responded poorly to DBS. Both had a longer duration from TD onset to surgery and older age at surgery. A cognitive and psychiatric decline was observed in the oldest patients, while no such decline ware observed in the younger patients. In most patients with TD, GPi-DBS could be a beneficial therapeutic option for long-term relief of TD. (Tokushima University Institutional Repository) ● Metadata: 116561 (Link to Publication Site) ● Publication site (DOI): 10.3390/life11060477 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34074009 ● Summary page in Scopus @ Elsevier: 2-s2.0-85107554331 (Tokushima University Institutional Repository: 116561, DOI: 10.3390/life11060477, PubMed: 34074009, Elsevier: Scopus)
9.	Daisy Ma Tabuena, Ryoma Morigaki, Ryosuke Miyamoto, Hideo Mure, Nobuaki Yamamoto, Kazuhisa Miyake, Taku Matsuda, Yuishin Izumi, Yasushi Takagi, P Rollin Tabuena and Toshitaka Kawarai : Ataxia with vitamin E deficiency in the Philippines: A case report of two siblings., The Journal of Medical Investigation : JMI, Vol.68, No.3.4, 400-403, 2021. (Summary) Here we report two siblings with ataxia and peripheral neuropathy. One patient showed head tremors. Genetic analysis revealed a mutation in the hepatic α-tocopherol transfer protein (α-TTP) gene (TTPA) on chromosome 8q13. They were diagnosed with ataxia with vitamin E deficiency which is firstly reported in the Philippines. As the symptoms of ataxia with vitamin E deficiency can be alleviated with lifelong vitamin E administration, differential diagnosis from similar syndromes is important. In addition, ataxia with vitamin E deficiency causes movement disorders. Therefore, a common hereditary disease in the Philippines, X-linked dystonia-parkinsonism, could be another differential diagnosis. The Philippines is an archipelago comprising 7,107 islands, and the prevalence of rare hereditary diseases among the populations of small islands is still unclear. For neurologists, establishing a system of genetic diagnosis and counseling in rural areas remains challenging. These unresolved problems should be addressed in the near future. J. Med. Invest. 68 : 400-403, August, 2021. (Keyword) Ataxia / Humans / Philippines / Siblings / Vitamin E Deficiency (Tokushima University Institutional Repository) ● Metadata: 116574 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.68.400 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34759169 ● Search Scopus @ Elsevier (PMID): 34759169 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.68.400 (Tokushima University Institutional Repository: 116574, DOI: 10.2152/jmi.68.400, PubMed: 34759169)
10.	Nobuaki Yamamoto, Yuishin Izumi, Yuki Yamamoto, K Kuroda, Izumi Yamaguchi, Shu Sogabe, Takeshi Miyamoto, Kenji Shimada, Yasuhisa Kanematsu, Ryoma Morigaki and Yasushi Takagi : Factors associated with DWI-ASPECTS score in patients with acute ischemic stroke due to cerebral large vessel occlusion, Clinical Neurology and Neurosurgery, Vol.199, 106316, 2020. (Summary) The Alberta Stroke Program Early CT score (ASPECTS) of patients with acute ischemic stroke at the time of admission varies. It is crucial to select appropriate methods of treatment, such as recombinant tissue-plasminogen activator, and/or endovascular thrombectomy. According to the recent guidelines, endovascular thrombectomy for patients with large vessel occlusion (LVO) and lesion of ischemic tissue that was not yet infarcted is effective. This result demonstrates the importance of patient selection based on neuroradiological imaging. However, there are many patients who are judged as ineligibility for recanalization therapy because of presence of large ischemic core, indicating unfavorable ASPECTS, at the time of admission. We investigated the factors associated with favorable diffusion-weighted image (DWI)-ASPECTS score at the time of admission. We studies patients with LVO within 24 h from onset who were admitted into our hospital. We divided them into two groups, with favorable DWI-ASPECTS (≥6), and unfavorable DWI-ASPECTS (<6) at the time of admission. We investigated factors associated with favorable DWI-ASPECTS by evaluation of our patients' severity of clinical symptom, etiology, and radiological findings. This study showed that mild white matter lesion (Fazekas scale ≤1), absence of internal carotid artery (ICA) occlusion and cardioembolic stroke were independent factor of favorable DWI-ASPECTS at the time of admission. (odds ratio 12.92, p < 0.001, odds ratio 0.31, p = 0.001, odds ratio 0.16, p = 0.001, respectively) CONCLUSIONS: Absence of severe white matter lesion, cardioembolic stroke, and ICA occlusion might be associated with favorable DWI-ASPECTS at the time of admission. (Keyword) Aged / Aged, 80 and over / Brain Ischemia / Cerebrovascular Disorders / Diffusion Magnetic Resonance Imaging / Female / Humans / Ischemic Stroke / Male / Middle Aged / Patient Admission / Prospective Studies / Retrospective Studies / Severity of Illness Index (Link to Publication Site) ● Publication site (DOI): 10.1016/j.clineuro.2020.106316 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33161217 ● Search Scopus @ Elsevier (PMID): 33161217 ● Search Scopus @ Elsevier (DOI): 10.1016/j.clineuro.2020.106316 (DOI: 10.1016/j.clineuro.2020.106316, PubMed: 33161217)
11.	Ryoma Morigaki, Ryosuke Miyamoto, Hideo Mure, Koji Fujita, Taku Matsuda, Yoko Yamamoto, Masahito Nakataki, Tetsuya Okahisa, Yuki Matsumoto, Kazuhisa Miyake, Nobuaki Yamamoto, Ryuji Kaji, Yasushi Takagi and Satoshi Goto : Can Pallidal Deep Brain Stimulation Rescue Borderline Dystonia? Possible Coexistence of Functional (Psychogenic) and Organic Components., Brain Sciences, Vol.10, No.9, 636, 2020. (Summary) The diagnosis and treatment of functional movement disorders are challenging for clinicians who manage patients with movement disorders. The borderline between functional and organic dystonia is often ambiguous. Patients with functional dystonia are poor responders to pallidal deep brain stimulation (DBS) and are not good candidates for DBS surgery. Thus, if patients with medically refractory dystonia have functional features, they are usually left untreated with DBS surgery. In order to investigate the outcome of functional dystonia in response to pallidal DBS surgery, we retrospectively included five patients with this condition. Their dystonia was diagnosed as organic by dystonia specialists and also as functional according to the Fahn and Williams criteria or the Gupta and Lang Proposed Revisions. Microelectrode recordings in the globus pallidus internus of all patients showed a cell-firing pattern of bursting with interburst intervals, which is considered typical of organic dystonia. Although their clinical course after DBS surgery was incongruent to organic dystonia, the outcome was good. Our results question the possibility to clearly differentiate functional dystonia from organic dystonia. We hypothesized that functional dystonia can coexist with organic dystonia, and that medically intractable dystonia with combined functional and organic features can be successfully treated by DBS surgery. (Tokushima University Institutional Repository) ● Metadata: 116502 (Link to Publication Site) ● Publication site (DOI): 10.3390/brainsci10090636 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 32942724 ● Search Scopus @ Elsevier (PMID): 32942724 ● Search Scopus @ Elsevier (DOI): 10.3390/brainsci10090636 (Tokushima University Institutional Repository: 116502, DOI: 10.3390/brainsci10090636, PubMed: 32942724)
12.	Hideo Mure, Naoto Toyoda, Ryoma Morigaki, Koji Fujita and Yasushi Takagi : Clinical Outcome and Intraoperative Neurophysiology of the Lance-Adams Syndrome Treated with Bilateral Deep Brain Stimulation of the Globus Pallidus Internus: A Case Report and Review of the Literature., Stereotactic and Functional Neurosurgery, Vol.98, No.6, 399-403, 2020. (Summary) Our results show that impairment in the basal ganglion circuitry might be involved in the pathogenesis of myoclonus in patients with LAS. (Keyword) Aged / Deep Brain Stimulation / Female / Globus Pallidus / Humans / Hypoxia-Ischemia, Brain / Intraoperative Neurophysiological Monitoring / Microelectrodes / Myoclonus / Treatment Outcome (Link to Publication Site) ● Publication site (DOI): 10.1159/000509318 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 32894852 ● Search Scopus @ Elsevier (PMID): 32894852 ● Search Scopus @ Elsevier (DOI): 10.1159/000509318 (DOI: 10.1159/000509318, PubMed: 32894852)
13.	Makoto Kinoshita, Masahito Nakataki, Ryoma Morigaki, Satsuki Sumitani, Satoshi Goto, Ryuji Kaji and Tetsuro Ohmori : Turning on the Left Side Electrode Changed Depressive State to Manic State in a Parkinson's Disease Patient Who Received Bilateral Subthalamic Nucleus Deep Brain Stimulation: A Case Report., Clinical Psychopharmacology and Neuroscience, Vol.16, No.4, 494-496, 2018. (Summary) No previous reports have described a case in which deep brain stimulation elicited an acute mood swing from a depressive to manic state simply by switching one side of the bilateral deep brain stimulation electrode on and off. The patient was a 68-year-old woman with a 10-year history of Parkinson's disease. She underwent bilateral subthalamic deep brain stimulation surgery. After undergoing surgery, the patient exhibited hyperthymia. She was scheduled for admission. On the first day of admission, it was clear that resting tremors in the right limbs had relapsed and her hyperthymia had reverted to depression. It was discovered that the left-side electrode of the deep brain stimulation device was found to be accidentally turned off. As soon as the electrode was turned on, motor impairment improved and her mood switched from depression to mania. The authors speculate that the lateral balance of stimulation plays an important role in mood regulation. The current report provides an intriguing insight into possible mechanisms of mood swing in mood disorders. (Tokushima University Institutional Repository) ● Metadata: 114301 (Link to Publication Site) ● Publication site (DOI): 10.9758/cpn.2018.16.4.494 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 30466222 ● Summary page in Scopus @ Elsevier: 2-s2.0-85055838752 (Tokushima University Institutional Repository: 114301, DOI: 10.9758/cpn.2018.16.4.494, PubMed: 30466222, Elsevier: Scopus)
14.	Toshitaka Kawarai, Ryosuke Miyamoto, Eiji Nakagawa, Reiko Koichihara, Takashi Sakamoto, Hideo Mure, Ryoma Morigaki, Hidetaka Koizumi, Ryosuke Oki, Celeste Montecchiani, Carlo Caltagirone, Antonio Orlacchio, Ayako Hattori, Hideaki Mashimo, Yuishin Izumi, Takahiro Mezaki, Satoko Kumada, Makoto Taniguchi, Fusako Yokochi, Shinji Saitoh, Satoshi Goto and Ryuji Kaji : Phenotype variability and allelic heterogeneity in KMT2B-Associated disease., Parkinsonism & Related Disorders, 2018. (Summary) We further demonstrate the allelic heterogeneity and phenotypic variations of KMT2B-associated disease. Haploinsufficiency is one of molecular pathomechanisms underlying the disease. Cardinal clinical features include combined dystonia accompanying mild psychomotor disability. Cerebellum would be affected in KMT2B-associated disease. (Keyword) Dystonia (Link to Publication Site) ● Publication site (DOI): 10.1016/j.parkreldis.2018.03.022 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29653907 ● Search Scopus @ Elsevier (PMID): 29653907 ● Search Scopus @ Elsevier (DOI): 10.1016/j.parkreldis.2018.03.022 (DOI: 10.1016/j.parkreldis.2018.03.022, PubMed: 29653907)
15.	Hideo Mure, Ryoma Morigaki, Ryosuke Miyamoto, Masahito Nakataki, 岡久哲也, Shinsuke Katoh, Ryuji Kaji, Yasushi Takagi, Shinji Nagahiro and Satoshi Goto : Multi-disciplinary approach for dystonia patients by treatment with deep brain stimulation, Functional Neurosurgery, Vol.57, 35-39, 2018. (Keyword) ジストニア / 脳深部刺激療法 / 多職種連携 / Dystonia / DBS / Multidisciplinary / Collaboration (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520572358412476800 (CiNii: 1520572358412476800)
16.	Toshitaka Kawarai, Ryoma Morigaki, Ryuji Kaji and Satoshi Goto : Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag)., Brain Sciences, Vol.7, No.7, 72, 2017. (Summary) X-linked dystonia-parkinsonism (XDP; OMIM314250), also referred to as DYT3 dystonia or "Lubag" disease, was first described as an endemic disease in the Philippine island of Panay. XDP is an adult-onset movement disorder characterized by progressive and severe dystonia followed by overt parkinsonism in the later years of life. Among the primary monogenic dystonias, XDP has been identified as a transcriptional dysregulation syndrome with impaired expression of the TAF1 (TATA box-binding protein associated factor 1) gene, which is a critical component of the cellular transcription machinery. The major neuropathology of XDP is progressive neuronal loss in the neostriatum (i.e., the caudate nucleus and putamen). XDP may be used as a human disease model to elucidate the pathomechanisms by which striatal neurodegeneration leads to dystonia symptoms. In this article, we introduce recent advances in the understanding of the interplay between pathophysiology and genetics in XDP. (Tokushima University Institutional Repository) ● Metadata: 114300 (Link to Publication Site) ● Publication site (DOI): 10.3390/brainsci7070072 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28672841 ● Summary page in Scopus @ Elsevier: 2-s2.0-85021763034 (Tokushima University Institutional Repository: 114300, DOI: 10.3390/brainsci7070072, PubMed: 28672841, Elsevier: Scopus)
17.	Ryoma Morigaki and Satoshi Goto : Striatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity., Brain Sciences, Vol.7, No.6, 2017. (Summary) Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by the expansion of a CAG trinucleotide repeat encoding an abnormally long polyglutamine tract (PolyQ) in the huntingtin (Htt) protein. In HD, striking neuropathological changes occur in the striatum, including loss of medium spiny neurons and parvalbumin-expressing interneurons accompanied by neurodegeneration of the striosome and matrix compartments, leading to progressive impairment of reasoning, walking and speaking abilities. The precise cause of striatal pathology in HD is still unknown; however, accumulating clinical and experimental evidence suggests multiple plausible pathophysiological mechanisms underlying striatal neurodegeneration in HD. Here, we review and discuss the characteristic neurodegenerative patterns observed in the striatum of HD patients and consider the role of various huntingtin-related and striatum-enriched proteins in neurotoxicity and neuroprotection. (Tokushima University Institutional Repository) ● Metadata: 114299 (Link to Publication Site) ● Publication site (DOI): 10.3390/brainsci7060063 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28590448 ● Search Scopus @ Elsevier (PMID): 28590448 ● Search Scopus @ Elsevier (DOI): 10.3390/brainsci7060063 (Tokushima University Institutional Repository: 114299, DOI: 10.3390/brainsci7060063, PubMed: 28590448)
18.	Hideo Mure, Ryoma Morigaki, Shinya Ohkita, Ryosuke Miyamoto, Ryuji Kaji, Shinji Nagahiro and Satoshi Goto : ジストニアに対する脳深部刺激療法:淡蒼球刺激と視床刺激の併用, Functional Neurosurgery, Vol.55, 80-86, 2016. (Keyword) ジストニア / 脳深部刺激療法 / 淡蒼球内接 / 視床吻腹側核 / Dystonia / DBS / GPi / Thalamic Vo nucleus (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520853833839457024 (CiNii: 1520853833839457024)
19.	Ryoma Morigaki, Hideo Mure, Ryuji Kaji, Shinji Nagahiro and Satoshi Goto : Therapeutic Perspective on Tardive Syndrome with Special Reference to Deep Brain Stimulation, Frontiers in Psychiatry, Vol.7, 207, 2016. (Summary) Tardive syndrome (TDS) is a potentially permanent and irreversible hyperkinetic movement disorder caused by exposure to dopamine receptor blocking agents. Guidelines published by the American Academy of Neurology recommend pharmacological first-line treatment for TDS with clonazepam (level B), ginkgo biloba (level B), amantadine (level C), and tetrabenazine (level C). Recently, a class II study provided level C evidence for use of deep brain stimulation (DBS) of the globus pallidus internus (GPi) in patients with TDS. Although the precise pathogenesis of TDS remains to be elucidated, the beneficial effects of GPi-DBS in patients with TDS suggest that the disease may be a basal ganglia disorder. In addition to recent advances in understanding the pathophysiology of TDS, this article introduces the current use of DBS in the treatment of medically intractable TDS. (Tokushima University Institutional Repository) ● Metadata: 114470 (Link to Publication Site) ● Publication site (DOI): 10.3389/fpsyt.2016.00207 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28082923 ● Summary page in Scopus @ Elsevier: 2-s2.0-85009160109 (Tokushima University Institutional Repository: 114470, DOI: 10.3389/fpsyt.2016.00207, PubMed: 28082923, Elsevier: Scopus)
20.	Ryoma Morigaki and Satoshi Goto : Putaminal Mosaic Visualized by Tyrosine Hydroxylase Immunohistochemistry in the Human Neostriatum., Frontiers in Neuroanatomy, Vol.10, 2016. (Summary) Among the basal ganglia-thalamocortical circuits, the putamen plays a critical role in the "motor" circuits that control voluntary movements and motor learning. The human neostriatum comprises two functional subdivisions known as the striosome (patch) and matrix compartments. Accumulating evidence suggests that compartment-specific dysregulations of dopamine activity might be involved in the disease-specific pathology and symptoms of human striatal diseases including movement disorders. This study was undertaken to examine whether or how striatal dopaminergic innervations are organized into the compartmentalized architecture found in the putamen of adult human brains. For this purpose, we used a highly sensitive immunohistochemistry (IHC) technique to identify tyrosine hydroxylase (TH; EC 1.14.16.2), a marker for striatal dopaminergic axons and terminals, in formalin-fixed paraffin-embedded (FFPE) tissues obtained from autopsied human brains. Herein, we report that discrete compartmentalization of TH-labeled innervations occurs in the putamen, as in the caudate nucleus (CN), with a higher density of TH labeling in the matrix compared to the striosomes. Our results provide anatomical evidence to support the hypothesis that compartment-specific dysfunction of the striosome-matrix dopaminergic systems might contribute to the genesis of movement disorders. (Tokushima University Institutional Repository) ● Metadata: 114298 (Link to Publication Site) ● Publication site (DOI): 10.3389/fnana.2016.00034 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27092059 ● Search Scopus @ Elsevier (PMID): 27092059 ● Search Scopus @ Elsevier (DOI): 10.3389/fnana.2016.00034 (Tokushima University Institutional Repository: 114298, DOI: 10.3389/fnana.2016.00034, PubMed: 27092059)
21.	Shinya Ohkita, Hideo Mure, Ryoma Morigaki, Shinji Nagahiro and Satoshi Goto : 小児の全身性ジストニアに対し脳深部刺激術を施行した1例, 小児の脳神経, Vol.41, No.1, 86, 2016.
22.	Ryoma Morigaki, Ryosuke Miyamoto, Shinya Ohkita, Yoshifumi Mizobuchi, Hideo Mure, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : Nuclear factor kappa b is under the control of dopamine signaling in the mouse striatum, Neurologia Medico-Chirurgica, Vol.55, 305, 2016.
23.	Ryoma Morigaki and Satoshi Goto : Postsynaptic Density Protein 95 in the Striosome and Matrix Compartments of the Human Neostriatum., Frontiers in Neuroanatomy, Vol.9, 154, 2015. (Summary) The human neostriatum consists of two functional subdivisions referred to as the striosome (patch) and matrix compartments. The striosome-matrix dopamine systems play a central role in cortico-thalamo-basal ganglia circuits, and their involvement is thought to underlie the genesis of multiple movement and behavioral disorders, and of drug addiction. Human neuropathology also has shown that striosomes and matrix have differential vulnerability patterns in several striatal neurodegenerative diseases. Postsynaptic density protein 95 (PSD-95), also known as disks large homolog 4, is a major scaffolding protein in the postsynaptic densities of dendritic spines. PSD-95 is now known to negatively regulate not only N-methyl-D-aspartate glutamate signaling, but also dopamine D1 signals at sites of postsynaptic transmission. Accordingly, a neuroprotective role for PSD-95 against dopamine D1 receptor (D1R)-mediated neurotoxicity in striatal neurodegeneration also has been suggested. Here, we used a highly sensitive immunohistochemistry technique to show that in the human neostriatum, PSD-95 is differentially concentrated in the striosome and matrix compartments, with a higher density of PSD-95 labeling in the matrix compartment than in the striosomes. This compartment-specific distribution of PSD-95 was strikingly complementary to that of D1R. In addition to the possible involvement of PSD-95-mediated synaptic function in compartment-specific dopamine signals, we suggest that the striosomes might be more susceptible to D1R-mediated neurotoxicity than the matrix compartment. This notion may provide new insight into the compartment-specific vulnerability of MSNs in striatal neurodegeneration. (Tokushima University Institutional Repository) ● Metadata: 114468 (Link to Publication Site) ● Publication site (DOI): 10.3389/fnana.2015.00154 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26648848 ● Search Scopus @ Elsevier (PMID): 26648848 ● Search Scopus @ Elsevier (DOI): 10.3389/fnana.2015.00154 (Tokushima University Institutional Repository: 114468, DOI: 10.3389/fnana.2015.00154, PubMed: 26648848)
24.	Ryosuke Miyamoto, Hiroyuki Sumikura, Toshiaki Takeuchi, Mitsuru Sanada, Koji Fujita, Toshitaka Kawarai, Hideo Mure, Ryoma Morigaki, Satoshi Goto, Shigeo Murayama, Yuishin Izumi and Ryuji Kaji : Autopsy case of severe generalized dystonia and static ataxia with marked cerebellar atrophy., Neurology, Vol.85, No.17, 1522-1524, 2015. (Keyword) Asphyxia / Atrophy / Autopsy / brain / Cerebellar Ataxia / cerebellum / Dysphonia / Dystonic Disorders / Humans / male / Middle Aged / Prone Position (Link to Publication Site) ● Publication site (DOI): 10.1212/WNL.0000000000002061 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26408497 ● Search Scopus @ Elsevier (PMID): 26408497 ● Search Scopus @ Elsevier (DOI): 10.1212/WNL.0000000000002061 (DOI: 10.1212/WNL.0000000000002061, PubMed: 26408497)
25.	Satoshi Goto, Ryoma Morigaki, Shinya Okita, Shinji Nagahiro and Ryuji Kaji : Development of a highly sensitive immunohistochemical method to detect neurochemical molecules in formalin-fixed and paraffin-embedded tissues from autopsied human brains., Frontiers in Neuroanatomy, Vol.9, No.22, 2015. (Summary) Immunohistochemistry (IHC) is a valuable method for identifying discrete neurochemical molecules by the interaction of target antigens with validated antibodies tagged with a visible label (e.g., peroxidase). We have developed an immunostaining method that is highly sensitive in detection of neurochemical antigens. Our IHC method, which we call the PBTA method, involves a hybrid protocol that implements aspects of both the polymer and avidin-biotin-complex (ABC) methods in combination with biotin-tyramide amplification. When using [Met]-enkephalin as a target antigen, the sensitivity of the PBTA method for IHC was more than 100-fold higher compared with the polymer and ABC methods. In addition, its sensitivity for enzyme-linked immunosorbent assay was about 1,000-fold higher compared with the ABC method. We examined the utility of our IHC method for both chromogenic and fluorescence detection systems used to visualize neurochemical peptides and proteins in formalin-fixed, paraffin-embedded tissues from autopsied human brains. The results convincingly demonstrate that under optimal conditions, our IHC method is highly sensitive without increasing non-specific background activities. Our IHC method could be a powerful tool for detection and visualization of neurochemical antigens that are present even in trace amounts in autopsied human brains. (Tokushima University Institutional Repository) ● Metadata: 114466 (Link to Publication Site) ● Publication site (DOI): 10.3389/fnana.2015.00022 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25784860 ● Summary page in Scopus @ Elsevier: 2-s2.0-84925154247 (Tokushima University Institutional Repository: 114466, DOI: 10.3389/fnana.2015.00022, PubMed: 25784860, Elsevier: Scopus)
26.	Hideo Mure, Ryoma Morigaki, Hidetaka Koizumi, Shinya Okita, Toshitaka Kawarai, Ryosuke Miyamoto, Ryuji Kaji, Shinji Nagahiro and Satoshi Goto : Deep brain stimulation of the thalamic ventral lateral anterior nucleus for DYT6 dystonia., Stereotactic and Functional Neurosurgery, Vol.92, No.6, 393-396, 2014. (Summary) The thalamic VLa nucleus could serve as an alternative target in DBS therapy for DYT6 dystonia. (Keyword) dystonia / deep brain stimulation / DYT6 / mutation / hereditary dystonia (Link to Publication Site) ● Publication site (DOI): 10.1159/000365577 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25359437 ● Summary page in Scopus @ Elsevier: 2-s2.0-84910089742 (DOI: 10.1159/000365577, PubMed: 25359437, Elsevier: Scopus)
27.	Hidetaka Koizumi, Satoshi Goto, Shinya Okita, Ryoma Morigaki, Norio Akaike, Yasushi Torii, Tetsuhiro Harakawa, Akihiro Ginnaga and Ryuji Kaji : Spinal Central Effects of Peripherally Applied Botulinum Neurotoxin A in Comparison between Its Subtypes A1 and A2., Frontiers in Neurology, Vol.5, No.98, 2014. (Summary) Because of its unique ability to exert long-lasting synaptic transmission blockade, botulinum neurotoxin A (BoNT/A) is used to treat a wide variety of disorders involving peripheral nerve terminal hyperexcitability. However, it has been a matter of debate whether this toxin has central or peripheral sites of action. We employed a rat model in which BoNT/A1 or BoNT/A2 was unilaterally injected into the gastrocnemius muscle. On time-course measurements of compound muscle action potential (CMAP) amplitudes after injection of BoNT/A1 or BoNT/A2 at doses ranging from 1.7 to 13.6 U, CMAP amplitude for the ipsilateral hind leg was markedly decreased on the first day, and this muscle flaccidity persisted up to the 14th day. Of note, both BoNT/A1 and BoNT/A2 administrations also resulted in decreased CMAP amplitudes for the contralateral leg in a dose-dependent manner ranging from 1.7 to 13.6 U, and this muscle flaccidity increased until the fourth day and then slowly recovered. Immunohistochemical results revealed that BoNT/A-cleaved synaptosomal-associated protein of 25 kDa (SNAP-25) appeared in the bilateral ventral and dorsal horns 4 days after injection of BoNT/A1 (10 U) or BoNT/A2 (10 U), although there seemed to be a wider spread of BoNT/A-cleaved SNAP-25 associated with BoNT/A1 than BoNT/A2 in the contralateral spinal cord. This suggests that the catalytically active BoNT/A1 and BoNT/A2 were axonally transported via peripheral motor and sensory nerves to the spinal cord, where they spread through a transcytosis (cell-to-cell trafficking) mechanism. Our results provide evidence for the central effects of intramuscularly administered BoNT/A1 and BoNT/A2 in the spinal cord, and a new insight into the clinical effects of peripheral BoNT/A applications. (Tokushima University Institutional Repository) ● Metadata: 114463 (Link to Publication Site) ● Publication site (DOI): 10.3389/fneur.2014.00098 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25002857 ● Search Scopus @ Elsevier (PMID): 25002857 ● Search Scopus @ Elsevier (DOI): 10.3389/fneur.2014.00098 (Tokushima University Institutional Repository: 114463, DOI: 10.3389/fneur.2014.00098, PubMed: 25002857)
28.	Akie Tanabe, Yukio Yamamura, Jiro Kasahara, Ryoma Morigaki, Ryuji Kaji and Satoshi Goto : A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson's disease., Frontiers in Cellular Neuroscience, Vol.8, No.50, 2014. (Summary) Abnormal motor behaviors in Parkinson's disease (PD) result from striatal dysfunction due to an imbalance between dopamine and glutamate transmissions that are integrated by dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32). c-Abelson tyrosine kinase (c-Abl) phosphorylates cyclin-dependent kinase 5 (Cdk5) at Tyr15 to increase the activity of Cdk5, which reduces the efficacy of dopaminergic signaling by phosphorylating DARPP-32 at Thr75 in the striatum. Here, we report that in the mouse striatum, a novel c-Abl inhibitor, nilotinib (AMN107), inhibits phosphorylation of both Cdk5 at Tyr15 and DARPP-32 at Thr75, which is negatively regulated by dopamine receptor activation through a D2 receptor-mediated mechanism. Like a D2-agonist, nilotinib synergizes with a D1-agonist for inducing striatal c-Fos expression. Moreover, systemic administration of nilotinib normalizes striatal motor behaviors in a mouse model of PD induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. These findings suggest that nilotinib could possibly serve as a new and alternative agent for treating PD motor symptoms. (Tokushima University Institutional Repository) ● Metadata: 114464 (Link to Publication Site) ● Publication site (DOI): 10.3389/fncel.2014.00050 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 24600352 ● Summary page in Scopus @ Elsevier: 2-s2.0-84894260952 (Tokushima University Institutional Repository: 114464, DOI: 10.3389/fncel.2014.00050, PubMed: 24600352, Elsevier: Scopus)
29.	Nobuaki Yamamoto, Yuka Terasawa, Junichiro Satomi, Ryoma Morigaki, Koji Fujita, Yuishin Izumi, Shinji Nagahiro and Ryuji Kaji : Reversibility of ischemic findings on 3-tesla magnetic resonance T2()-weighted image after recanalization, The Journal of Medical Investigation : JMI, Vol.61, No.1,2, 190-196, 2014. (Summary) Ischemic vessel signs (IVS) can be detected on 3-tesla T2()-weighted magnetic resonance images as a vessel enlargement at the territory of acute ischemia caused by major vessel occlusion or stenosis. Here, we studied changes in IVS before and after recanalization by the administration of intravenous recombinant tissue plasminogen activator (IV rtPA), carotid artery stenting or percutaneous transluminal angioplasty in patients with major vessel occlusion or stenosis. We performed magnetic resonance imaging for all patients treated by IV rtPA at the time of admission, shortly after and 24-72 hours after treatment with IV rtPA. We reviewed the IVS to assess its natural course of IVS by assessing patients who did not recanalize. IVS tended to disappear after recanalization. Conversely, in patients without recanalization, IVS did not disappear shortly after IV rtPA; rather, it disappeared 24-72 hours after IV rtPA, especially in the presence of complete infarction. Recanalization by IV rtPA or endovascular treatment contributed to improved clinical deficits or the prevention from further progression. IVS can be a parameter of misery perfusion and an important factor to detect the patients who have an indication of treatment for recanalization. (Keyword) Administration, Intravenous / Aged / Aged, 80 and over / Angioplasty / Carotid Arteries / Carotid Stenosis / Diffusion Magnetic Resonance Imaging / Disease Progression / Female / Humans / ischemia / Male / Middle Aged / Retrospective Studies / Stents / Time Factors / Tissue Plasminogen Activator / Treatment Outcome (Tokushima University Institutional Repository) ● Metadata: 109553 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.61.190 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 24705765 ● Summary page in Scopus @ Elsevier: 2-s2.0-84897951917 (Tokushima University Institutional Repository: 109553, DOI: 10.2152/jmi.61.190, PubMed: 24705765, Elsevier: Scopus)
30.	Yuka Terasawa, Nobuaki Yamamoto, Ryoma Morigaki, Koji Fujita, Yuishin Izumi, Junichiro Satomi, Masafumi Harada, Shinji Nagahiro and Ryuji Kaji : Brush sign on 3-T t2-weighted MRI as a potential predictor of hemorrhagic transformation after tissue plasminogen activator therapy, Stroke, Vol.45, No.1, 274-276, 2014. (Summary) The brush sign (BS) is the enlargement of medullary veins on 3-T T2-weighted MRI seen in patients with ischemic stroke because of major cerebral artery occlusion. However, the clinical relevance of BS in patients with acute stroke remains unclear. We assessed the correlation between detecting BS with the development of hemorrhagic transformation after intravenous thrombolysis. We enrolled consecutive patients with M1 or M2 occlusion treated with intravenous tissue plasminogen activator. We classified the patients into 2 groups: the group positive for BS (P-BS) and the group negative for BS (N-BS). We investigated the differences in MRI findings and the clinical outcome between the 2 groups. The subjects consisted of 36 patients (19 men; mean age, 74.7 years). Twenty-one patients (58%) had M1 occlusion, and 15 (42%) had M2 occlusion. Twenty-five patients (69%) were classified into the P-BS group and 11 (31%) into the N-BS group. Recanalization was observed in 15 (60%) and 10 (90%) patients in the P-BS and N-BS groups, respectively (P=0.116). Hemorrhagic transformation on MRI was observed more frequently in the P-BS group than in the N-BS group (64% versus 18%; P=0.027). A good outcome (mRS, 0-1) at discharge was found in 24% of patients in the P-BS group and in 45% of patients in the N-BS group (P=0.152). A multivariate logistic regression analysis revealed that the presence of BS (odds ratio, 9.08; 95% confidence interval, 1.4-59.8; P=0.022) was independently associated with hemorrhagic transformation. BS may predict the development of hemorrhagic transformation in patients with acute stroke treated with intravenous tissue plasminogen activator. (Keyword) Aged / Aged, 80 and over / Cerebral Hemorrhage / Disease Progression / Female / Fibrinolytic Agents / Humans / Image Processing, Computer-Assisted / Intracranial Embolism / Magnetic Resonance Imaging / Male / Middle Aged / Prognosis / Prospective Studies / Stroke / Thrombolytic Therapy / Tissue Plasminogen Activator / Treatment Outcome (Link to Publication Site) ● Publication site (DOI): 10.1161/STROKEAHA.113.002640 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 24172577 ● Summary page in Scopus @ Elsevier: 2-s2.0-85027928664 (DOI: 10.1161/STROKEAHA.113.002640, PubMed: 24172577, Elsevier: Scopus)
31.	Ryoma Morigaki, Toshitaka Kawarai, Shinya Ohkita, Hideo Mure, 小泉英貴, Yoshifumi Mizobuchi, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : X-linked dystonia-parkinsonismのニューロペプチドYシステム, Functional Neurosurgery, Vol.53, 47-55, 2014. (Keyword) X-linked dystonia-parkinsonism / DYT3 / Neuropeptide Y / Striatum / Striosome (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520290884129170304 (CiNii: 1520290884129170304)
32.	Hidetaka Koizumi, Ryoma Morigaki, Shinya Ohkita, Shinji Nagahiro, Masanori Nakagawa and Satoshi Goto : Response of striosomal opioid signaling to dopamine depletion in 6-hydroxydopamine-lesioned rat model of Parkinsons disease: a potential compensatory role, Frontiers in Cellular Neuroscience, Vol.7, 74, 2013. (Summary) The opioid peptide receptors consist of three major subclasses, namely, μ, δ, and κ (MOR, DOR, and KOR, respectively). They are involved in the regulation of striatal dopamine functions, and increased opioid transmissions are thought to play a compensatory role in altered functions of the basal ganglia in Parkinson's disease (PD). In this study, we used an immunohistochemistry with tyramide signal amplification (TSA) protocols to determine the distributional patterns of opioid receptors in the striosome-matrix systems of the rat striatum. As a most striking feature of striatal opioid anatomy, MORs are highly enriched in the striosomes and subcallosal streak. We also found that DORs are localized in a mosaic pattern in the dorsal striatum (caudate-putamen), with heightened labeling for DOR in the striosomes relative to the matrix compartment. In the 6-hydroxydopamine-lesioned rat model of PD, lesions of the nigrostriatal pathways caused a significant reduction of striatal labeling for both the MOR and DOR in the striosomes, but not in the matrix compartment. Our results suggest that the activities of the striosome and matrix compartments are differentially regulated by the opioid signals involving the MORs and DORs, and that the striosomes may be more responsive to opioid peptides (e.g., enkephalin) than the matrix compartment. Based on a model in which the striosome compartment regulates the striatal activity, we propose a potent compensatory role of striosomal opioid signaling under the conditions of the striatal dopamine depletion that occurs in PD. (Tokushima University Institutional Repository) ● Metadata: 114465 (Link to Publication Site) ● Publication site (DOI): 10.3389/fncel.2013.00074 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23730270 ● Summary page in Scopus @ Elsevier: 2-s2.0-84877285159 (Tokushima University Institutional Repository: 114465, DOI: 10.3389/fncel.2013.00074, PubMed: 23730270, Elsevier: Scopus)
33.	Satoshi Goto, Toshitaka Kawarai, Ryoma Morigaki, Shinya Okita, Hidetaka Koizumi, Shinji Nagahiro, L Edwin Munoz, V Lillian Lee and Ryuji Kaji : Defects in the striatal neuropeptide Y system in X-linked dystonia-parkinsonism., Brain, Vol.136, No.Pt 5, 1555-1567, 2013. (Summary) Neuropeptide Y is a novel bioactive substance that plays a role in the modulation of neurogenesis and neurotransmitter release, and thereby exerts a protective influence against neurodegeneration. Using a sensitive immunohistochemical method with a tyramide signal amplification protocol, we performed a post-mortem analysis to determine the striatal localization profile of neuropeptide Y in neurologically normal individuals and in patients with X-linked dystonia-parkinsonism, a major representative of the neurodegenerative diseases that primarily involve the striatum. All of the patients examined were genetically verified as having X-linked dystonia-parkinsonism. In normal individuals, we found a scattered distribution of neuropeptide Y-positive neurons and numerous nerve fibres labelled for neuropeptide Y in the striatum. Of particular interest was a differential localization of neuropeptide Y immunoreactivity in the striatal compartments, with a heightened density of neuropeptide Y labelling in the matrix compartment relative to the striosomes. In patients with X-linked dystonia-parkinsonism, we found a significant decrease in the number of neuropeptide Y-positive cells accompanied by a marked loss of their nerve fibres in the caudate nucleus and putamen. The patients with X-linked dystonia-parkinsonism also showed a lack of neuropeptide Y labelling in the subventricular zone, where a marked loss of progenitor cells that express proliferating cell nuclear antigen was found. Our results indicate a neostriatal defect of the neuropeptide Y system in patients with X-linked dystonia-parkinsonism, suggesting its possible implication in the mechanism by which a progressive loss of striatal neurons occurs in X-linked dystonia-parkinsonism. (Link to Publication Site) ● Publication site (DOI): 10.1093/brain/awt084 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23599389 ● Search Scopus @ Elsevier (PMID): 23599389 ● Search Scopus @ Elsevier (DOI): 10.1093/brain/awt084 (DOI: 10.1093/brain/awt084, PubMed: 23599389)
34.	Yukio Yamamura, Ryoma Morigaki, Jiro Kasahara, Hironori Yokoyama, Akie Tanabe, Shinya Ohkita, Hidetaka Koizumi, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice, Frontiers in Cellular Neuroscience, Vol.7, No.12, 1-10, 2013. (Summary) Striatal functions depend on the activity balance between the dopamine and glutamate neurotransmissions. Glutamate inputs activate cyclin-dependent kinase 5 (Cdk5), which inhibits postsynaptic dopamine signaling by phosphorylating DARPP-32 (dopamine- and cAMP-regulated phosphoprotein, 32 kDa) at Thr75 in the striatum. c-Abelson tyrosine kinase (c-Abl) is known to phosphorylate Cdk5 at Tyr15 (Tyr15-Cdk5) and thereby facilitates the Cdk5 activity. We here report that Cdk5 with Tyr15 phosphorylation (Cdk5-pTyr15) is enriched in the mouse striatum, where dopaminergic stimulation inhibited phosphorylation of Tyr15-Cdk5 by acting through the D2 class dopamine receptors. Moreover, in the 1-methyl-4-phenyl-1,2,4,6-tetrahydropyridine (MPTP) mouse model, dopamine deficiency caused increased phosphorylation of both Tyr15-Cdk5 and Thr75-DARPP-32 in the striatum, which could be attenuated by administration of L-3,4-dihydroxyphenylalanine and imatinib (STI-571), a selective c-Abl inhibitor. Our results suggest a functional link of Cdk5-pTyr15 with postsynaptic dopamine and glutamate signals through the c-Abl kinase activity in the striatum. (Tokushima University Institutional Repository) ● Metadata: 114613 (Link to Publication Site) ● Publication site (DOI): 10.3389/fncel.2013.00012 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23420105 ● Search Scopus @ Elsevier (PMID): 23420105 ● Search Scopus @ Elsevier (DOI): 10.3389/fncel.2013.00012 (Tokushima University Institutional Repository: 114613, DOI: 10.3389/fncel.2013.00012, PubMed: 23420105)
35.	Hiroyuki Ishiura, Wataru Sako, Mari Yoshida, Toshitaka Kawarai, Osamu Tanabe, Jun Goto, Yuji Takahashi, Hidetoshi Date, Jun Mitsui, Budrul Ahsan, Yaeko Ichikawa, Atsushi Iwata, Hiide Yoshino, Yuishin Izumi, Koji Fujita, Kouji Maeda, Satoshi Goto, Hidetaka Koizumi, Ryoma Morigaki, Masako Ikemura, Naoko Yamauchi, Shigeo Murayama, A Garth Nicholson, Hidefumi Ito, Gen Sobue, Masanori Nakagawa, Ryuji Kaji and Shoji Tsuji : The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement., American Journal of Human Genetics, Vol.91, No.2, 320-329, 2012. (Summary) Hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P) is an autosomal-dominant neurodegenerative disorder characterized by widespread fasciculations, proximal-predominant muscle weakness, and atrophy followed by distal sensory involvement. To date, large families affected by HMSN-P have been reported from two different regions in Japan. Linkage and haplotype analyses of two previously reported families and two new families with the use of high-density SNP arrays further defined the minimum candidate region of 3.3 Mb in chromosomal region 3q12. Exome sequencing showed an identical c.854C>T (p.Pro285Leu) mutation in the TRK-fused gene (TFG) in the four families. Detailed haplotype analysis suggested two independent origins of the mutation. Pathological studies of an autopsied patient revealed TFG- and ubiquitin-immunopositive cytoplasmic inclusions in the spinal and cortical motor neurons. Fragmentation of the Golgi apparatus, a frequent finding in amyotrophic lateral sclerosis, was also observed in the motor neurons with inclusion bodies. Moreover, TAR DNA-binding protein 43 kDa (TDP-43)-positive cytoplasmic inclusions were also demonstrated. In cultured cells expressing mutant TFG, cytoplasmic aggregation of TDP-43 was demonstrated. These findings indicate that formation of TFG-containing cytoplasmic inclusions and concomitant mislocalization of TDP-43 underlie motor neuron degeneration in HMSN-P. Pathological overlap of proteinopathies involving TFG and TDP-43 highlights a new pathway leading to motor neuron degeneration. (Keyword) Base Sequence / Chromosomes, Human, Pair 3 / DNA-Binding Proteins / Exome / Genetic Linkage / Genetic Predisposition to Disease / Golgi Apparatus / Haplotypes / Hereditary Sensory and Motor Neuropathy / Humans / Inclusion Bodies / Japan / Molecular Sequence Data / Motor Neurons / Pedigree / Point Mutation / Polymorphism, Single Nucleotide / Proteins / Sequence Analysis, DNA (Link to Publication Site) ● Publication site (DOI): 10.1016/j.ajhg.2012.07.014 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22883144 ● Search Scopus @ Elsevier (PMID): 22883144 ● Search Scopus @ Elsevier (DOI): 10.1016/j.ajhg.2012.07.014 (DOI: 10.1016/j.ajhg.2012.07.014, PubMed: 22883144)
36.	Ryoma Morigaki, Kyong-Hon Pooh, Kenji Shouno, Hidekazu Taniguchi, Shouichi Endo and Yoshinobu Nakagawa : Choroid plexus papilloma in a girl with hypomelanosis of Ito., Journal of Neurosurgery. Pediatrics, Vol.10, No.3, 182-185, 2012. (Summary) The authors report a case of choroid plexus papilloma in a girl with hypomelanosis of Ito, and they review the literature in brief. Hypomelanosis of Ito is a rare neurocutaneous syndrome characterized by cutaneous hypopigmented whorls, streaks, and patches along lines of Blaschko. Most patients exhibit CNS manifestations, including psychomotor retardation, seizures, hypotonia, and ataxia. A 6-year-old girl with hypomelanosis of Ito was referred to the authors' hospital with bilateral tumors in the lateral ventricles. The right lateral ventricle tumor was surgically removed. Immunohistochemical investigations revealed the tumor to be a choroid plexus papilloma (WHO Grade I). A chromosomal investigation revealed that the tumor tissue demonstrated a large loss of heterozygosity at chromosome 10. The case reported here serves as a reminder that de novo brain tumors may arise in patients with chromosomal mosaicism. (Keyword) Child / Chromosomes, Human, Pair 10 / Female / Humans / Hypopigmentation / Immunohistochemistry / Intellectual Disability / Lateral Ventricles / Loss of Heterozygosity / Magnetic Resonance Imaging / Papilloma, Choroid Plexus (Tokushima University Institutional Repository) ● Metadata: 114558 (Link to Publication Site) ● Publication site (DOI): 10.3171/2012.5.PEDS11556 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22793165 ● Search Scopus @ Elsevier (PMID): 22793165 ● Search Scopus @ Elsevier (DOI): 10.3171/2012.5.PEDS11556 (Tokushima University Institutional Repository: 114558, DOI: 10.3171/2012.5.PEDS11556, PubMed: 22793165)
37.	Ryosuke Miyamoto, Satoshi Goto, Wataru Sako, Ai Miyashiro, Isabelle Kim, Fabienne Escande, Masafumi Harada, Ryoma Morigaki, Koutaro Asanuma, Yoshifumi Mizobuchi, Shinji Nagahiro, Yuishin Izumi and Ryuji Kaji : Generalized dystonia in a patient with a novel mutation in the GLUD1 gene, Movement Disorders, Vol.27, No.9, 1198-1199, 2012. (Keyword) Adolescent / Deep Brain Stimulation / Dystonic Disorders / Electroencephalography / Epilepsy, Tonic-Clonic / Female / Glutamate Dehydrogenase / Humans / Hyperinsulinism / Mutation / Polymerase Chain Reaction (Link to Publication Site) ● Publication site (DOI): 10.1002/mds.25081 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22730017 ● Summary page in Scopus @ Elsevier: 2-s2.0-84864777670 (DOI: 10.1002/mds.25081, PubMed: 22730017, Elsevier: Scopus)
38.	Toshiyuki Okazaki, Teruyoshi Kageji, Kazuyuki Kuwamura, Keiko T. Kitazato, Hideo Mure, Keijiro Hara, Ryoma Morigaki, Yoshifumi Mizobuchi, Kazuhito Matsuzaki and Shinji Nagahiro : Up-regulation of endogenous PML induced by a combination of interferon-beta and temozolomide enhances p73/YAP-mediated apoptosis in glioblastoma, Cancer Letters, Vol.323, No.2, 199-207, 2012. (Summary) Interferon-beta (IFN-) is reported to augment anti-tumor effects by temozolomide in glioblastoma via down-regulation of MGMT. Promyelocytic leukemia (PML), a gene induced by IFN-, is a tumor suppressor. Here, we report for the first time that in combination therapy, an IFN--induced increase in endogenous PML contributes to anti-tumor effects in p53 wild- and mutant glioma cells in a xenograft mice model. The increased PML promoted the accumulation of p73, a structural and functional homolog of p53, to fuse the coactivator Yes-associated-protein in the PML nuclear bodies. The adjuvant therapy targeted at PML may be a promising therapeutic strategy for glioblastoma. (Keyword) Apoptosis / Base Sequence / Blotting, Western / Brain Neoplasms / Cell Line, Tumor / DNA Primers / DNA-Binding Proteins / Dacarbazine / Glioblastoma / Humans / Interferon-beta / Nuclear Proteins / Real-Time Polymerase Chain Reaction / Transcription Factors / Tumor Suppressor Proteins / Up-Regulation (Link to Publication Site) ● Publication site (DOI): 10.1016/j.canlet.2012.04.013 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22542810 ● Search Scopus @ Elsevier (PMID): 22542810 ● Search Scopus @ Elsevier (DOI): 10.1016/j.canlet.2012.04.013 (DOI: 10.1016/j.canlet.2012.04.013, PubMed: 22542810)
39.	Ryoma Morigaki, Junichiro Satomi, E Shikata and Shinji Nagahiro : Aneurysm of the lateral spinal artery: A case report, Clinical Neurology and Neurosurgery, Vol.114, 713-716, 2012. (Keyword) Aged / Arterial Occlusive Diseases / Arteries / Cerebral Angiography / Cervical Vertebrae / Embolization, Therapeutic / Endovascular Procedures / Headache / Humans / Magnetic Resonance Angiography / Magnetic Resonance Imaging / Male / Spinal Diseases / Subarachnoid Hemorrhage / Tomography, X-Ray Computed / Treatment Outcome (Link to Publication Site) ● Publication site (DOI): 10.1016/j.clineuro.2011.12.003 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22257516 ● Search Scopus @ Elsevier (PMID): 22257516 ● Search Scopus @ Elsevier (DOI): 10.1016/j.clineuro.2011.12.003 (DOI: 10.1016/j.clineuro.2011.12.003, PubMed: 22257516)
40.	S Okita, Ryoma Morigaki, H Koizumi, Ryuji Kaji, Shinji Nagahiro and Satoshi Goto : Cell type-specific localization of optineurin in the striatal neurons of mice: Implications for neuronal vulnerability in huntington's disease, Neuroscience, Vol.202, No.27, 363-370, 2012. (Summary) Striatal neuropathology of Huntington's disease (HD) involves primary and progressive degeneration of the medium-sized projection neurons, with relative sparing of the local circuit interneurons. The mechanism for such a patterned cell loss in the HD striatum continues to remain unclear. Optineurin (OPTN) is one of the proteins interacting with huntingtin and plays a protective role in several neurodegenerative disorders. To determine the cellular localization pattern of OPTN in the mouse striatum, we employed a highly sensitive immunohistochemistry with the tyramide signal amplification system. In this study, we show that OPTN appeared as a cytoplasmic protein within the subsets of the striatal neurons. Of particular interest was that OPTN was abundantly expressed in the interneurons, whereas low levels of OPTN were observed in the medium projection neurons. This cell type-specific distribution of OPTN in the striatum is strikingly complementary to the pattern of neuronal loss typically observed in the striatum of patients with HD. We suggest that OPTN abundance is an important cellular factor in considering the cell type-specific vulnerability of striatal neurons in HD. (Keyword) Animals / Blotting, Western / cell death / Corpus Striatum / Densitometry / Eye Proteins / Glutamic Acid / Huntington Disease / Image Processing, Computer-Assisted / immunohistochemistry / Interneurons / Male / Mice / Mice, Inbred C57BL / Mice, Transgenic / Mutation / Neurons / Serotonin Plasma Membrane Transport Proteins (Tokushima University Institutional Repository) ● Metadata: 116978 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.neuroscience.2011.11.059 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22155493 ● Search Scopus @ Elsevier (PMID): 22155493 ● Search Scopus @ Elsevier (DOI): 10.1016/j.neuroscience.2011.11.059 (Tokushima University Institutional Repository: 116978, DOI: 10.1016/j.neuroscience.2011.11.059, PubMed: 22155493)
41.	Ryoma Morigaki, Toshitaka Kawarai, Masahito Nakataki, Junichi Iga, Wataru Sako, Yoshifumi Mizobuchi, Shinji Nagahiro, Satoshi Goto and Ryuji Kaji : Clinical characteristics of X-linked dystonia-parkinsonism, Functional Neurosurgery, Vol.50, 150-153, 2011. (Keyword) X-linked dystonia parkinsonism / DYT3 / Clinical symptoms / Adaptibity of daily life / Striatal compartments (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1571135651154880768 (CiNii: 1571135651154880768)
42.	Ryoma Morigaki, Wataru Sako, Shinya Okita, Jiro Kasahara, Hironori Yokoyama, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : Cyclin-dependent kinase 5 with phosphorylation of tyrosine 15 residue is enriched in striatal matrix compartment in adult mice, Neuroscience, Vol.189, 25-31, 2011. (Summary) Accumulating evidence suggests that the striosome-matrix systems have a tight link with motor and behavioral brain functions and their disorders. Cyclin-dependent kinase 5 (Cdk5) is a versatile protein kinase that plays a role in synaptic functions and cell survival in adult brain, and its kinase activity is stimulated by phosphorylation at tyrosine 15 residue (pY15). In this study, we used an immunohistochemical method to show differential localization of Cdk5-pY15 in the striatal compartments of adult mice, with a heightened density of Cdk5-pY15 labeling in the matrix relative to the striosomes. Our findings indicate that Cdk5-pY15 can be a new marker for the striatal matrix compartment, and suggest a possible involvement of Cdk5-mediated signaling in compartment-specific neurotransmission and disease pathology in the striatum. (Keyword) Animals / Corpus Striatum / Cyclin-Dependent Kinase 5 / immunohistochemistry / Mice / phosphorylation / Tyrosine (Link to Publication Site) ● Publication site (DOI): 10.1016/j.neuroscience.2011.05.055 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21640796 ● Summary page in Scopus @ Elsevier: 2-s2.0-79960905477 (DOI: 10.1016/j.neuroscience.2011.05.055, PubMed: 21640796, Elsevier: Scopus)
43.	Wataru Sako, Ryoma Morigaki, Ryuji Kaji, Ikuo Tooyama, Shinya Okita, Keiko Kitazato, Shinji Nagahiro, M Ann Graybiel and Satoshi Goto : Identification and localization of a neuron-specific isoform of TAF1 in rat brain: implications for neuropathology of DYT3 dystonia, Neuroscience, Vol.189, 100-107, 2011. (Summary) The neuron-specific isoform of the TAF1 gene (N-TAF1) is thought to be involved in the pathogenesis of DYT3 dystonia, which leads to progressive neurodegeneration in the striatum. To determine the expression pattern of N-TAF1 transcripts, we developed a specific monoclonal antibody against the N-TAF1 protein. Here we show that in the rat brain, N-TAF1 protein appears as a nuclear protein within subsets of neurons in multiple brain regions. Of particular interest is that in the striatum, the nuclei possessing N-TAF1 protein are largely within medium spiny neurons, and they are distributed preferentially, though not exclusively, in the striosome compartment. The compartmental preference and cell type-selective distribution of N-TAF1 protein in the striatum are strikingly similar to the patterns of neuronal loss in the striatum of DYT3 patients. Our findings suggest that the distribution of N-TAF1 protein could represent a key molecular characteristic contributing to the pattern of striatal degeneration in DYT3 dystonia. (Keyword) Amino Acid Sequence / Animals / Base Sequence / brain / Corpus Striatum / Dystonia / Histone Acetyltransferases / Molecular Sequence Data / Nuclear Proteins / Protein Isoforms / Rats / Rats, Sprague-Dawley / TATA-Binding Protein Associated Factors / Transcription Factor TFIID (Link to Publication Site) ● Publication site (DOI): 10.1016/j.neuroscience.2011.05.031 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21616129 ● Summary page in Scopus @ Elsevier: 2-s2.0-79960914214 (DOI: 10.1016/j.neuroscience.2011.05.031, PubMed: 21616129, Elsevier: Scopus)
44.	Ryoma Morigaki, Kyong-Hon Pooh and Yoshinobu Nakagawa : Endoscopic transaqueductal placement of a single-catheter cyst-ventriculoperitoneal shunt in a neonate with Dandy-Walker malformation-associated hydrocephalus: case report., Neurologia Medico-Chirurgica, Vol.51, No.3, 256-259, 2011. (Summary) A neonate with hydrocephalus associated with Dandy-Walker malformation was successfully treated with an endoscopic placement of a transaqueductal ventricular single catheter. The modified catheter was provided with additional fenestration on its proximal side to allow simultaneous drainage from both the supra- and infratentorial compartments. This technique is well known for isolated fourth ventricles, but has not been applied to hydrocephalus associated with Dandy-Walker malformation. The cyst-ventriculoperitoneal shunt effectively drained both compartments. The patient was doing well 18 months after the surgical procedure. Endoscopic transaqueductal shunt placement can be considered, especially in patients with aqueductal patency. (Keyword) Catheters, Indwelling / Cerebral Aqueduct / Dandy-Walker Syndrome / Humans / Hydrocephalus / Infant / Infant, Newborn / Male / Neuroendoscopy / Treatment Outcome / Ventriculoperitoneal Shunt / Ventriculostomy (Link to Publication Site) ● Publication site (DOI): 10.2176/nmc.51.256 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21441750 ● Search Scopus @ Elsevier (PMID): 21441750 ● Search Scopus @ Elsevier (DOI): 10.2176/nmc.51.256 (DOI: 10.2176/nmc.51.256, PubMed: 21441750)
45.	Wataru Sako, Ryoma Morigaki, Yoshifumi Mizobuchi, Takashi Tsuzuki, Hiroyuki Ima, Y Ushio, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : Bilateral pallidal deep brain stimulation in primary Meige syndrome, Parkinsonism & Related Disorders, Vol.17, No.2, 123-125, 2011. (Summary) Primary Meige syndrome is an idiopathic movement disorder that manifests as craniofacial and often cervical dystonias. Deep brain stimulation (DBS) of the globus pallidus internus (GPi) has emerged as a powerful surgical option in the treatment of primary generalized or segmental dystonia. However, the experience with GPi-DBS in Meige syndrome is limited. We followed 5 patients with disabling Meige syndrome treated by bilateral GPi-DBS for 49 ± 43.7 (mean ± SD) months. All patients were assessed before surgery and at the last follow-up after surgery using the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) which includes both the movement and disability scales. Bilateral GPi-DBS produced a sustained and long-lasting improvement in dystonia symptoms associated with Meige syndrome. At the last follow-up, the mean scores of BFMDRS movement and disability scales improved significantly by 84 ± 6.8% (range, 75-94%) and 89 ± 8.1% (range, 80-100%), respectively. Bilateral pallidal stimulation is a beneficial therapeutic option for long-term relief of the disabling dystonia symptoms in Meige syndrome. (Keyword) Aged / Deep Brain Stimulation / Female / Globus Pallidus / Humans / Male / Meige Syndrome / Middle Aged / Treatment Outcome (Link to Publication Site) ● Publication site (DOI): 10.1016/j.parkreldis.2010.11.013 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21147544 ● Search Scopus @ Elsevier (PMID): 21147544 ● Search Scopus @ Elsevier (DOI): 10.1016/j.parkreldis.2010.11.013 (DOI: 10.1016/j.parkreldis.2010.11.013, PubMed: 21147544)
46.	Ryoma Morigaki, Kiyohito Shinno, Kyong-Hon Pooh and Yoshinobu Nakagawa : Giant glioependymal cyst in an infant., Journal of Neurosurgery. Pediatrics, Vol.7, No.2, 175-178, 2011. (Summary) The authors report the case of an infant with a giant glioependymal cyst. Although it has been suggested that these cysts originate from the tela choroidea, their origin remains controversial. This 35-month-old girl with truncal ataxia was referred to the authors' hospital. Magnetic resonance imaging revealed a giant cystic mass extending from the anterior to the posterior cranial fossa. Hydrocephalus was caused by obstruction of the sylvian aqueduct. Endoscopic fenestration of the cyst wall was performed. Histochemical and immunohistochemical staining identified the lesion as a glioependymal cyst. Magnetic resonance imaging performed 8 months later suggested that the cyst originated from the tela choroidea. At 5-year follow-up, there was no tumor recurrence and she had fully recovered. The origin of glioependymal cysts is discussed, and the authors suggest that their origin is the tela choroidea. (Keyword) Brain Diseases / Central Nervous System Cysts / Child, Preschool / Ependyma / Female / Humans (Link to Publication Site) ● Publication site (DOI): 10.3171/2010.11.PEDS10270 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21284464 ● Search Scopus @ Elsevier (PMID): 21284464 ● Search Scopus @ Elsevier (DOI): 10.3171/2010.11.PEDS10270 (DOI: 10.3171/2010.11.PEDS10270, PubMed: 21284464)
47.	Wataru Sako, Ryoma Morigaki, 宮本亮介, Ryuji Kaji, 溝渕桂史, Shinji Nagahiro and Satoshi Goto : -dropped head syndrome, Functional Neurosurgery, Vol.50, No.2, 115-118, 2011.
48.	Wataru Sako, Ryoma Morigaki, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : Olfactory type G-protein alpha subunit in striosome-matrix dopamine systems in adult mice, Neuroscience, Vol.170, No.2, 497-502, 2010. (Summary) There is a growing body of evidence that striosome-matrix dopamine systems are tightly linked with motor and behavioral brain functions and disorders. In this study, we used an immunohistochemical method to show differential expression of the olfactory type G-protein alpha subunit (Galphaolf) that involves in the coupling of dopamine D1 receptor with adenylyl cyclase in the striatal compartments of adult mice, and observed heightened density of Galphaolf labeling in the striosomes relative to the matrix compartment. Our findings suggest that Galphaolf could be one of the key molecules for controlling differential responses of the striosome and matrix compartments to dopamine D1 receptor signaling in the striatum of adult mice. (Keyword) Animals / Apomorphine / Corpus Striatum / Dopamine / Dopamine and cAMP-Regulated Phosphoprotein 32 / GTP-Binding Protein alpha Subunits / Mice / Neurons / Receptors, Dopamine D1 / Receptors, Opioid, mu / Signal Transduction / Tyrosine 3-Monooxygenase (Link to Publication Site) ● Publication site (DOI): 10.1016/j.neuroscience.2010.06.072 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 20603191 ● Summary page in Scopus @ Elsevier: 2-s2.0-77956189821 (DOI: 10.1016/j.neuroscience.2010.06.072, PubMed: 20603191, Elsevier: Scopus)
49.	Wataru Sako, Nagako Murase, Yoshifumi Mizobuchi, Ryoma Morigaki, Kazuhito Matsuzaki, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : Bilateral pallidal stimulation in Meige syndrome, Functional Neurosurgery, Vol.49, No.1, 94-95, 2010. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1571417124978153088 (CiNii: 1571417124978153088)
50.	Ryoma Morigaki, Masaaki Uno, Shunji Matsubara, Koichi Satoh and Shinji Nagahiro : Choreoathetosis due to rupture of a distal accessory anterior cerebral artery aneurysm, Cerebrovascular Diseases, Vol.25, No.3, 285-287, 2008. (Keyword) Aged / Aneurysm, Ruptured / Anterior Cerebral Artery / Athetosis / Cerebral Angiography / Chorea / Craniotomy / Embolization, Therapeutic / Female / Humans / Intracranial Aneurysm / Subarachnoid Hemorrhage / Tomography, X-Ray Computed / Vasodilator Agents (Link to Publication Site) ● Publication site (DOI): 10.1159/000119640 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 18332626 ● Search Scopus @ Elsevier (PMID): 18332626 ● Search Scopus @ Elsevier (DOI): 10.1159/000119640 (DOI: 10.1159/000119640, PubMed: 18332626)
51.	Ryoma Morigaki, Masaaki Uno, Atsuhiko Suzue and Shinji Nagahiro : Hemichorea due to hemodynamic ischemia associated with extracranial carotid artery stenosis. Report of two cases., Journal of Neurosurgery, Vol.105, No.1, 142-147, 2006. (Summary) In this paper the authors describe two patients with recurrent hemiparesis and limb shaking that gradually progressed to hemichorea. Cerebral angiography confirmed severe unilateral internal carotid artery stenosis (95%) contralateral to the hemichorea. The cerebral blood flow, assessed using N-isopropyl-p-(iodine-123) iodoamphetamine single-photon emission computed tomography (SPECT), disclosed markedly decreased vascular reserves in both patients. After carotid endarterectomy was performed, the hemichorea gradually subsided and SPECT confirmed increased cerebral perfusion. The results in these cases indicate that surgical revascularization is effective for hemichorea due to cerebral ischemia with reduced vascular reserve. (Keyword) Aged / Brain Ischemia / Carotid Artery, Internal / Carotid Stenosis / Chorea / Endarterectomy, Carotid / Female / Humans / Male (Link to Publication Site) ● Publication site (DOI): 10.3171/jns.2006.105.1.142 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 16871890 ● Search Scopus @ Elsevier (PMID): 16871890 ● Search Scopus @ Elsevier (DOI): 10.3171/jns.2006.105.1.142 (DOI: 10.3171/jns.2006.105.1.142, PubMed: 16871890)
52.	S Kudo, Ryoma Morigaki, J Saito, M Ikeda, K Oka and K Tanishita : Shear-stress effect on mitochondrial membrane potential and albumin uptake in cultured endothelial cells., Biochemical and Biophysical Research Communications, Vol.270, No.2, 616-621, 2000. (Summary) Endothelial cells (ECs) that line the inner surface of blood vessels are continuously exposed to shear stress induced by blood flow in vivo, and shear stress affects ATP-dependent macromolecular transport in ECs. However, the relationship between the ATP production and shear stress is still unclear. We, therefore, evaluated mitochondrial ATP synthesis activity in cultured endothelial cells exposed to shear stress, using a confocal laser scanning microscope (CLSM) and a mitochondrial membrane potential probe (5,5',6,6'-tetrachloro-1,1',3, 3'-tetraethyl-benzimidazolycarbocyanine iodide, JC-1). Low shear stress (10 dyn/cm(2)) increased mitochondrial membrane potential by 30%. On the contrary, high shear stress (60 dyn/cm(2)) decreased it by 20%. This observation was consistent with the ATP-dependent albumin uptake into endothelial cells. Our results indicate that ATP synthetic activity is related to the albumin uptake into endothelial cells. (Keyword) Adenosine Triphosphate / Albumins / Animals / Benzimidazoles / Carbocyanines / Cells, Cultured / Endothelium, Vascular / Fluorescent Dyes / Membrane Potentials / Stress, Mechanical / Swine (Link to Publication Site) ● Publication site (DOI): 10.1006/bbrc.2000.2482 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 10753672 ● Search Scopus @ Elsevier (PMID): 10753672 ● Search Scopus @ Elsevier (DOI): 10.1006/bbrc.2000.2482 (DOI: 10.1006/bbrc.2000.2482, PubMed: 10753672)

Academic Paper (Unrefereed Paper):

1.	小山広士, Shinya Ohkita, Hideo Mure, Ryoma Morigaki, Ryuji Kaji, Satoshi Goto and Shinji Nagahiro : 症例報告第17回若手奨励賞受賞論文遅発性ジストニア(tardive dystonia)に対して脳深部刺激術を施行した5例, Shikoku Acta Medica, Vol.73, No.3 4, 193-196, 2017. (Summary) We assessed the efficiency of pallidal deep brain stimulation for tardive dystonia. This search was carried out in Electronic chart of Tokushima University Hospital. 5 patients with tardive dystonia were enrolled. GPi(internal segment of globus pallidus)was the target in all patients. The motor part of Burke-Fahn-Marsden Dystonia Rating Scale(BFMDRS)was improved by 78．4% on average when compared to preoperative BFMDRS scores. The performed analysis indicates that GPi-DBS is an effective and safe treatment for tardive dystonia. (Keyword) deep brain stimulation / globus pallidus internus / tardive dyskinesia / tardive syndrome / Burke-Fahn-Marsden dystonia rating scale(BFMDRS) (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050865122807275264 (CiNii: 1050865122807275264)
2.	Wataru Sako, Ryuji Kaji, Ryosuke MIYAMOTO, Ryoma Morigaki, Yoshifumi Mizobuchi, Shinji Nagahiro and Satoshi Goto : Conservative treatment strategy in patients with dystonia, Functional Neurosurgery, Vol.50, No.1, 36-37, 2011. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1573387449814655232 (CiNii: 1573387449814655232)
3.	Wataru Sako, Ryoma Morigaki, Takashi TSUZUKI, Hiroyuki IMA, Yukitaka USHIO, Yoshifumi Mizobuchi, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : Bilateral pallidal stimulation in Meige syndrome, Functional Neurosurgery, Vol.50, No.1, 46-47, 2011. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1572824499861230208 (CiNii: 1572824499861230208)
4.	Ryoma Morigaki, Wataru Sako, Yoshifumi Mizobuchi, Shinji Nagahiro, Satoshi Goto and Ryuji Kaji : Clinical characteristics of X-linked dystonia-parkinsonism, Functional Neurosurgery, Vol.50, No.1, 48-49, 2011. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1571417124977670272 (CiNii: 1571417124977670272)
5.	Wataru Sako, Ryosuke MIYAMOTO, Ryuji Kaji, Ryoma Morigaki, Yoshifumi Mizobuchi, Shinji Nagahiro and Satoshi Goto : Bilateral subthalamic stimulation for dropped head syndrome in Parkinson's disease, Functional Neurosurgery, Vol.50, No.1, 108-109, 2011. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1572261549908102016 (CiNii: 1572261549908102016)
6.	Wataru Sako, Ryoma Morigaki, Yoshifumi Mizobuchi, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : Meige症候群に対する両側淡蒼球刺激術, Functional Neurosurgery, Vol.49, No.2, 148-151, 2010. (Keyword) Meige症候群(合併症,外科的療法) / 淡蒼球 / 発病年齢 / 顔面けいれん(病因) / *脳深部刺激 / ヒト / 成人(19∼44) / 中年(45∼64) / 高齢者(65∼79) / 男 / 女 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1573105974837985664 (CiNii: 1573105974837985664)
7.	Wataru Sako, Nagako Murase, Yoshifumi Mizobuchi, Ryoma Morigaki, Kazuhito Matsuzaki, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : Vo-complex thalamotomy and pallidal stimulation in focal hand dystonia, Functional Neurosurgery, Vol.49, No.1, 98-99, 2010. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1574231874745267840 (CiNii: 1574231874745267840)
8.	Ryoma Morigaki, Masaaki Uno, Shunji Matsubara, Koichi Satoh, Atsuhiko Suzue, Yoshifumi Mizobuchi, Wataru Sako, Ryuji Kaji, Shinji Nagahiro and Satoshi Goto : Involuntary movements due to cerebrovascular disease : Three case reports, Functional Neurosurgery, Vol.49, No.1, 60-61, 2010. (Keyword) 塞栓術 / 脳血管障害(合併症,外科的療法) / 舞踏病(病因) / 頸動脈内膜切除術 / 不随意運動 / coiled-coil motif / Homo sapiens / 高齢者(65∼79) / 男 / 女 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1572261549908344832 (CiNii: 1572261549908344832)

Academic Letter:

1.	Ryoma Morigaki, Masahito Nakataki, Toshitaka Kawarai, Lillian V. Lee, Rosalia A. Teleg, Ma Daisy P. Tabuena, Hideo Mure, Wataru Sako, Paul Matthew D. Pasco, Shinji Nagahiro, Junichi Iga, Tetsuro Ohmori, Satoshi Goto and Ryuji Kaji : Depression in X-linked dystonia-parkinsonism:A case-control study, Parkinsonism & Related Disorders, Vol.19, No.9, 844-846, 2013. (Keyword) Case-Control Studies / Depression / Dystonic Disorders / Genetic Diseases, X-Linked / Heredodegenerative Disorders, Nervous System / Humans / Male / Parkinson Disease (Link to Publication Site) ● Publication site (DOI): 10.1016/j.parkreldis.2013.04.027 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23706616 ● Summary page in Scopus @ Elsevier: 2-s2.0-84880785140 (DOI: 10.1016/j.parkreldis.2013.04.027, PubMed: 23706616, Elsevier: Scopus)

Review, Commentary:

1.	Ryoma Morigaki and Ryosuke Miyamoto : Dystonia: Still a Mysterious Syndrome., Life, Vol.12, No.7, Jul. 2022. (Summary) The diagnosis of dystonia is sometimes complicated due to its many clinical manifestations, causes, and the lack of specific diagnostic examinations or simple algorithms [...]. (Tokushima University Institutional Repository) ● Metadata: 117342 (Link to Publication Site) ● Publication site (DOI): 10.3390/life12070989 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35888079 ● Search Scopus @ Elsevier (PMID): 35888079 ● Search Scopus @ Elsevier (DOI): 10.3390/life12070989 (Tokushima University Institutional Repository: 117342, DOI: 10.3390/life12070989, PubMed: 35888079)
2.	Ryoma Morigaki and Satoshi Goto : ジストニアの脳内機序ー病理所見ー, Modern Physicaion 特集ジストニアとジスキネジア, Vol.37, No.6, 586-588, Jun. 2017.
3.	Ryoma Morigaki and Satoshi Goto : A short commentary on globus pallidus internus deep brain stimulation in primary Meige syndrome, Journal of Neurology & Neurophysiology, Vol.7, No.6, 2016. (Tokushima University Institutional Repository) ● Metadata: 114297 (Link to Publication Site) ● Publication site (DOI): 10.4172/2155-9562.1000405 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.4172/2155-9562.1000405 (Tokushima University Institutional Repository: 114297, DOI: 10.4172/2155-9562.1000405)
4.	Ryoma Morigaki and Ryuji Kaji : 不随意運動, The Journal of the Japan Medical Association, Vol.142, No.2, 95-96, Oct. 2013.

Proceeding of International Conference:

1.	Taku Matsuda, Ryoma Morigaki, Hiroaki Hayasawa, Hiroshi Koyama, Teruo Oda, Kazuhisa Miyake and Yasushi Takagi : Striatal parvalbumin interneurons, not cholinergic interneurons, are activated in a mouse model of cerebellar dystonia, NEURO2024, Fukuoka, Jul. 2024.
2.	Joji Fujikawa, Ryoma Morigaki, Kazuhisa Miyake, Taku Matsuda, Hiroshi Koyama, Teruo Oda, Nobuaki Yamamoto, Yuishin Izumi, Hideo Mure, Satoshi Goto and Yasushi Takagi : Cranial geometry in patients with dystonia, The 13th Scientific meeting of Asian Australasian Society for Stereotactic and Functional Neurosurgery (AASSFN 2023), Osaka, Apr. 2023.
3.	NAKANISHI Hiroshi, Ryoma Morigaki, Nobuaki Yamamoto, Joji Fujikawa, Teruo Oda, OMAE Hiroshi, Yuishin Izumi and Yasushi Takagi : The effect of Rikaba, a hybrid physical exercise salon for Parkinson's disease patients, The 13th Scientific meeting of Asian Australasian Society for Stereotactic and Functional Neurosurgery (AASSFN 2023), Osaka, Apr. 2023.
4.	Hideo Mure, Ryoma Morigaki, Ryosuke Miyamoto, Kazuhisa Miyake, Taku Matsuda, Hiroshi Koyama and Yasushi Takagi : Long-term follow-up of 12 patients treated with bilateral pallidal stimulation for tardive dystonia, 13th Scientific meeting of Asian Australasian Society for Streotactic and Functional Neurosurgery, Osaka, Apr. 2023.
5.	OMAE Hiroshi, Ryoma Morigaki, Kazuhisa Miyake, Taku Matsuda, 中野渡友香, Megumi Kuno, Tetsuya Matsuura and Yasushi Takagi : Cognitive changes due to subthalamic nucleus deep brain stimulation in elderly Parkinson's Disease, The 13th Scientific meeting of Asian Australasian Society for Stereotactic and Functional Neurosurgery (AASSFN 2023), Osaka, Apr. 2023.
6.	Ryoma Morigaki, Maya Anzai, Joji Fujikawa, Teruo Oda, Hayasawa Hiroaki, Matsuda Taku, Jiro Kasahara and Yasushi Takagi : Changes in phosphodiesterase 10A in mice model of levodopa-induced dyskinesia, The 13th Scientific meeting of Asian Australasian Society for Stereotactic and Functional Neurosurgery (AASSFN 2023), Osaka, Apr. 2023.
7.	Harumi Kadota, Shoma Fujisawa, Masaki Oono, Ryoma Morigaki, Nobuaki Yamamoto, Yasuhisa Kanematsu, Manabu Ishihara and Masami Shishibori : Development of a 3D visualization system for the cerebral aneurysm coil embolization, Proceedings Volume 11794, Fifteenth International Conference on Quality Control by Artificial Vision; 117940C (2021), Tokushima, Jul. 2021. (Link to Publication Site) ● Publication site (DOI): 10.1117/12.2589084 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.1117/12.2589084 (DOI: 10.1117/12.2589084)
8.	Ryoma Morigaki, Masatoshi Ogawa, Shinya Ohkita, Taku Matsuda, Yasushi Takagi and Satoshi Goto : Phospho-serine 276 of nuclear factor kappa b is involved in the genesis of l-dopa-induced dyskinesia, The Journal of Neuroscience, 2021.
9.	Ryoma Morigaki, Lee H Janifer, Yoshida Tomoko, Wuthrich Christian and Graybiel M Ann : Mu opioid receptors are strongly upregulated in the q175 mouse model of huntingtons disease, The Journal of Neuroscience, Chicago, IL, Oct. 2019.
10.	Ryoma Morigaki, S Okita, Hideo Mure, Yasushi Takagi and S Goto : Olfactory type g-protein alfa subunit related changes in the striatum underlie the genesis of L-DOPA induced dyskinesiaBrain and Brain PET2019, Brain and Brain PET2019, Jul. 2019.
11.	Ryoma Morigaki, Shinya Ohkita, Hideo Mure, Yasushi Takagi and Satoshi Goto : Olfactory type G-protein alfa subunit related changes in the striatum underlie the genesis of L-dopa-induced dyskinesia, Journal of Cerebral Blood Flow and Metabolism, Yokohama, Jun. 2019.
12.	Hideo Mure, Ryoma Morigaki, Shinya Ohkita, Ryosuke Miyamoto, Shinji Nagahiro and Satoshi Goto : Deep Brain Stimulation for Dystonia - Pallidal stimulation and thalamic stimulation, World Society for Stereotactic and Functional Neurosurgery, Berlin, Jun. 2017.
13.	Toshitaka Kawarai, Ryosuke Miyamoto, Hideo Mure, Ryoma Morigaki, Orlacchio Antonio, Koichihara Reiko, Nakagawa Eiji, Takashi Sakamoto, Yuishin Izumi, Satoshi Goto and Ryuji Kaji : Haploinsufficiency of KMT2B causes myoclonus-dystonia with impaired psychomotor ability, The MDS 21th International Congress of Parkinsons Disease and Movement Disorders, Jun. 2017. (Keyword) KMT2B / dystonia
14.	Jiro Kasahara, Yamamura Yukio, Tanabe Akie, Ryoma Morigaki, Ryuji Kaji and Satoshi Goto : Inhibition of c-Abelson tyrosine kinase (c-Abl) as a possible strategy for treatment of PD: Study in MPTP-induced mice model, The 12th International Conference on Alzheimers's and Parkinson;s Disease: AD/PD 2015, Mar. 2015.
15.	Nobuaki Yamamoto, Yuka Terasawa, Junichiro Satomi, Ryoma Morigaki, Koji Fujita, Masafumi Harada, Yuishin Izumi, Shinji Nagahiro and Ryuji Kaji : Reversibility of ischemic findings on 3-tesla magnetic resonance T2*-weighted image after recanalization, European Stroke Conference 2014, Nice, France, May 2014.
16.	Yoshifumi Mizobuchi, T Okazaki, Teruyoshi Kageji, Kazuyuki Kuwayama, KT Kitazato, Hideo Mure, Keijiro Hara, Ryoma Morigaki, Kazuhito Matsuzaki, Kohhei Nakajima, T Fujihara and Shinji Nagahiro : A combination of interferon-beta and temozolomide augments anti-tumor effects through p73/YAP-mediated apoptosis by PML in glioblastoma, The 4th Quadrennial Meeting of the World Federation of Neuro-Oncology held in conjunction with the 2013 SNO Scientific Meeting and Education Day, San Francisco, Nov. 2013.
17.	Junichiro Satomi, Shinji Nagahiro, Shunji Matsubara, Masaaki Uno, Koichi Satoh, Norio Nakajima, Kohhei Nakajima, Kyoko Nishi and Ryoma Morigaki : Combined treatment for intracranial giant aneurysms, 9th International Conference on Cerebrovascular Surgery, Nagoya, Nov. 2009.

Proceeding of Domestic Conference:

1.	Ryoma Morigaki, Hiroshi NAKANISHI, Teruo Oda, Joji Fujikawa, Hiroshi OMAE, Takamitsu Kawarasaki, Nobuaki Yamamoto, 立花亜由美, 尾崎智樹, Junichi Iga and Yasushi Takagi : Interdisciplinary Collaboration: Caregiving Medical Support System Originating from Parkinson's Salon., 日本脳神経外科学会第83回学術総会, Oct. 2024.
2.	Ryoma Morigaki : 凝固術と脳深部刺激療法の現状, 第43回日本脳神経超音波学会総会/第27回日本栓子検出と治療学会, Jun. 2024.
3.	Joji Fujikawa, Kazuhisa Miyake and Ryoma Morigaki : 脳深部刺激電極から得たLFPの解析(初級編), 第6回中国四国機能神経外科懇話会, Mar. 2024.
4.	Kazuhisa Miyake, Ryoma Morigaki and Yasushi Takagi : 脳深部刺激療法における電極の移動に関する2報告, 第6回中国四国機能神経外科懇話会, Mar. 2024.
5.	Ryoma Morigaki, Kazuhisa Miyake, Taku Matsuda and Yasushi Takagi : 赤核振戦に伴う痛みに対して著効した脳深部刺激療法の一例, 第6回中国四国機能神経外科懇話会, Mar. 2024.
6.	Ryoma Morigaki : How basic research on movement disorders benefit young physicians?, 第63回日本定位・機能神経外科学会, Feb. 2024.
7.	Ryoma Morigaki, Kazuhisa Miyake, Ryosuke Miyamoto, 大前博司, Taku Matsuda, Hiroshi Koyama, Yuishin Izumi and Yasushi Takagi : GPi-DBSが著効した外転型痙攣性発声障害の一例, 第63回日本定位機能外科学会, Feb. 2024.
8.	OMAE Hiroshi, Ryoma Morigaki, Kazuhisa Miyake, Taku Matsuda, 中野渡友香, 久野恵, Tetsuya Matsuura and Yasushi Takagi : 高齢パーキンソン病患者に対する視床下核脳深部刺激療法による変化の検討, 第36回日本老年脳神経外科学会, Apr. 2023.
9.	Ryoma Morigaki, Kazuhisa Miyake, Taku Matsuda, KOYAMA Hiroshi, Ryosuke Miyamoto, Yuishin Izumi, Masahito Nakataki, Ryuji Kaji, Satoshi Goto and Yasushi Takagi : Surgical Treatment for Combined Functional and Organic Dystonia, 第62回日本定位・機能神経外科学会, Jan. 2023.
10.	Ryoma Morigaki, Kazuhisa Miyake, KOYAMA Hiroshi, Taku Matsuda and Yasushi Takagi : Painful abdominal contraction and belly dancer's dyskinesia after STN-DBS in a patient with Parkinson's disease, 第62回日本定位・機能神経外科学会, Jan. 2023.
11.	Kazuhisa Miyake, Ryoma Morigaki, Taku Matsuda and Yasushi Takagi : GPi-DBSのinterleaving刺激により，パーキンソン病でのすくみ足に効果を認めた一例, 日本脳神経外科学会第81回学術総会, Sep. 2022.
12.	Ryoma Morigaki, Kazuhisa Miyake, Taku Matsuda, Ryosuke Miyamoto, Yuishin Izumi, Masahito Nakataki and Yasushi Takagi : 機能性要素を合併したジストニアへの手術加療, 日本脳神経外科学会第81回学術総会, Sep. 2022.
13.	Ryoma Morigaki : 教育コースジストニアを究める機能性ジストニア治療法としての外科的な治療ーDBS刺激の調整も含めて, 日本神経学会誌, May 2022.
14.	Nobuaki Yamamoto, 黒田一駿, Yuki Yamamoto, Yasuhisa Kanematsu, Ryoma Morigaki, Yuishin Izumi and Yasushi Takagi : 脳主幹動脈閉塞に対する血行再建術において有効再開通が得られた患者の予後関連因子, 第63回日本神経学会学術大会, May 2022.
15.	Kazuhisa Miyake, Ryoma Morigaki, Hideo Mure, Taku Matsuda, Satoshi Goto and Yasushi Takagi : Vo-DBS施行後から9年経過したDYT6ジストニア患者の長期予後, 日本定位・機能神経外科学会機関紙, Jan. 2022.
16.	Taku Matsuda, Ryoma Morigaki, Yuki Matsumoto, Hideo Mure, Kazuhisa Miyake, Masahito Nakataki, Masafumi Harada and Yasushi Takagi : 全身性ジストニアと強迫性障害の重症度についての検討, 日本定位・機能神経外科学会機関紙, Jan. 2022.
17.	Ryoma Morigaki, Joji Fujikawa, Taku Matsuda, Kazuhisa Miyake, Hideo Mure, Teruo Oda, Ryosuke Miyamoto, Koji Fujita, Nobuaki Yamamoto, 和泉唯心 and Yasushi Takagi : 特発性ジストニア患者の頭蓋骨の歪み, 日本定位・機能神経外科学会機関紙, Jan. 2022.
18.	Taku Matsuda, Ryoma Morigaki, Yuki Matsumoto, Hideo Mure, Kazuhisa Miyake, Masahito Nakataki, Masafumi Harada and Yasushi Takagi : 全身性ジストニアと強迫性障害の重症度についての検討, 第61回日本定位・機能神経外科学会, Jan. 2022.
19.	Manabu Ishihara, Yasuhisa Kanematsu, Nobuto Nakanishi, Ryoma Morigaki, Nobuaki Yamamoto, Jun Oto, Masami Shishibori and Yasushi Takagi : 日本ICU患者データベース(JIPAD)による急性期脳卒中症例の検討機械学習(データマイニング)を用いた解析, 日本脳神経外科学会学術総会, Oct. 2021.
20.	Taku Matsuda, Ryoma Morigaki, Yuki Matsumoto, Hideo Mure, Kazuhisa Miyake, Masahito Nakataki and Yasushi Takagi : 全身性ジストニアの重症度と強迫観念の関係性についての検討, 日本脳神経外科学会学術総会, Oct. 2021.
21.	Kazuhisa Miyake, Ryoma Morigaki, Hideo Mure and Yasushi Takagi : DYT6ジストニア患者におけるDBS術後9年の長期予後, 日本脳神経外科学会学術総会, Oct. 2021.
22.	Ryoma Morigaki, Joji Fujikawa, Teruo Oda, NAKANISHI Hiroshi, Nobuaki Yamamoto, Kazuhisa Miyake, Taku Matsuda and Yasushi Takagi : 機械学習を用いた脳線条体免疫染色画像の解析, 日本脳神経外科学会学術総会, Oct. 2021.
23.	Ryoma Morigaki, Eiji Shikata, Kazuhisa Miyake, Taku Matsuda and Yasushi Takagi : 神経刺激装置埋め込み術後の皮下血腫に対し漢方薬が奏功した3例, 第29回日本脳神経外科漢方医学会学術集会, Oct. 2021.
24.	Manabu Ishihara, Nobuto Nakanishi, Yasuhisa Kanematsu, Ryoma Morigaki, Nobuaki Yamamoto, Yasushi Takagi and Jun Oto : 日本ICU患者データベース(JIPAD)による急性期脳卒中症例の検討, Journal of the Japanese Society of Intensive Care Medicine, Feb. 2021.
25.	Ryoma Morigaki, Hideo Mure, Taku Matsuda, Kazuhisa Miyake, Ryosuke Miyamoto, Koji Fujita, Masahito Nakataki, Ryuji Kaji, Yasushi Takagi and Satoshi Goto : 機能ー器質ボーダーラインジストニアに対する脳深部刺激療法, 第60回日本定位・機能神経外科学会, Jan. 2021.
26.	Hideo Mure, Ryoma Morigaki, 小山広士, Kazuhisa Miyake, Taku Matsuda, Ryosuke Miyamoto, Koji Fujita, Yuishin Izumi, Satoshi Goto and Yasushi Takagi : 遅発性ジストニアに対する淡蒼球内節刺激術12例の検討ー適応・長期成績・刺激条件についてー, 第60回日本定位・機能神経外科学会, Jan. 2021.
27.	Kazuhisa Miyake, Taku Matsuda, Ryoma Morigaki, Hideo Mure, Yasushi Takagi and Ryosuke Miyamoto : ジストニックストームを生じたGNAO1遺伝子変異に対し淡蒼球脳深部刺激療法を行った1例, 第60回日本定位・機能神経外科学会, Jan. 2021.
28.	Taku Matsuda, Yuki Matsumoto, Ryoma Morigaki, Hideo Mure, Kazuhisa Miyake, Shinsuke Katoh, 尾藤良孝, Masafumi Harada and Yasushi Takagi : Quantitative parameter mappingを用いた3TMRIでの視床下核の可視化, 第60回日本定位・機能神経外科学会, Jan. 2021.
29.	Manabu Ishihara, Seiya Takemura, Yasuhisa Kanematsu, Ryoma Morigaki, Nobuaki Yamamoto, Jun Oto, Masaki Oono, Masami Shishibori and Yasushi Takagi : 機械的学習を用いた医療データの解析脳出血症例の検討, 第79回日本脳神経外科学会学術総会, Oct. 2020.
30.	Hideo Mure, Ryoma Morigaki, 小山広士, Shinya Ohkita, Taku Matsuda, Wataru Sako, Ryosuke Miyamoto, Koji Fujita, Yuishin Izumi, Ryuji Kaji, Satoshi Goto and Yasushi Takagi : 遅発性ジストニアに対する淡蒼球内節刺激術12例の検討:適応・長期成績・刺激条件について, 第79回日本脳神経外科学会総会, Oct. 2020.
31.	Ryoma Morigaki, 吉田智子, Wuthrich Christian, Crittenden R. Jill, 久保田康夫 and Graybiel M. Ann : Q175ハンチントン病モデルマウス線条体においてmu-オピオイド受容体の発現は進行性に強く増加する, 第79回日本脳神経外科学会学術総会, Oct. 2020.
32.	Ryosuke Miyamoto, 黒田一駿, Hideo Mure, Ryoma Morigaki, Masahito Nakataki, Yusuke Osaki, Yuishin Izumi, Satoshi Goto and Ryuji Kaji : 18p-症候群に伴う全身性ジストニアに対し，GPi-DBSが効果的であった一例, 第61回日本神経学会学術大会, Aug. 2020.
33.	Taku Matsuda, Ryoma Morigaki, Hideo Mure, Masahito Nakataki, 山本陽子, 豊田直人, Satoshi Goto and Yasushi Takagi : ジストニアと強迫性障害の関係についての検討, Functional Neurosurgery, 130, Jan. 2020.
34.	Hideo Mure, Koji Fujita, Ryoma Morigaki, Ryosuke Miyamoto, 松田拓, Satoshi Goto, Yasushi Takagi and Satoshi Goto : FDG PETを用いたジストニア患者の脳代謝ネットワークパターンの描出, Functional Neurosurgery, 132, Jan. 2020.
35.	Ryoma Morigaki, Hideo Mure, Taku Matsuda, Ryosuke Miyamoto, 山本陽子, 豊田直人, Yasushi Takagi and Satoshi Goto : GPi-DBSを施行したDYT-GNAL(DYT25)の一例, Functional Neurosurgery, 134, Jan. 2020.
36.	Ryosuke Miyamoto, Koji Fujita, Hideo Mure, Ryoma Morigaki, Masahito Nakataki, Yuishin Izumi, Satoshi Goto and Ryuji Kaji : ヒステリー性麻痺の臨床診断と電気生理心因性運動障害の診断心因性ジストニアを中心に, 第49回日本臨床神経生理学会学術大会, Nov. 2019.
37.	Ryoma Morigaki, Hideo Mure, Ryosuke Miyamoto, Taku Matsuda, 山本陽子, Yasushi Takagi and Satoshi Goto : 機能性ジストニアは器質性ジストニアスペクトラム障害か?, Neurologia Medico-Chirurgica, 349, Oct. 2019.
38.	Hideo Mure, Koji Fujita, Ryoma Morigaki, Ryosuke Miyamoto, Satoshi Goto and Yasushi Takagi : FDG PETを用いたジストニア患者の脳代謝ネットワークパターンの描出, 日本脳神経外科学会第78回学術集会, Oct. 2019.
39.	Hideo Mure, Ryoma Morigaki, Ryosuke Miyamoto, Masahito Nakataki, Yasushi Takagi, Ryuji Kaji, Shinji Nagahiro and Satoshi Goto : ジストニアDBS治療における多職種連携．, 第57回日本定位・機能神経外科学会, Jan. 2018.
40.	Hideo Mure, Ryoma Morigaki, Ryosuke Miyamoto, Masahito Nakataki, 岡久哲也, Yasushi Takagi, Ryuji Kaji, Shinji Nagahiro and Satoshi Goto : ジストニアDBS治療における多職種連携, 第57回日本定位・機能神経外科学会, Jan. 2018.
41.	Hideo Mure, Ryoma Morigaki, Ryosuke Miyamoto, Masahito Nakataki, Junichiro Satomi, Ryuji Kaji, Satoshi Goto and Shinji Nagahiro : ジストニアDBS治療におけるチーム医療の重要性 -徳島大学での取り組み-, 日本脳神経外科学会第76回学術総会, Oct. 2017.
42.	Ryoma Morigaki, Shinya Ohkita, Hideo Mure, Shinji Nagahiro and Satoshi Goto : L-ドーパ誘発性ジスキネジア発症におけるGαolf発現の変化, 日本脳神経外科学会第76回学術総会, Oct. 2017.
43.	亘雄也, Hideo Mure, Ryoma Morigaki, Shinya Ohkita, 西山徹 and Shinji Nagahiro : Lance-Adams症候群に対する両側淡蒼球内節刺激術の一施行例, 第83回日本脳神経外科学会中国四国支部学術集会, Apr. 2017.
44.	Hideo Mure, Shinya Ohkita, Ryoma Morigaki, Satoshi Goto and Shinji Nagahiro : 小児ジストニアに対する脳深部刺激療法の経験, 第21回四国脳神経外科カンファレンス, Aug. 2016.
45.	Shinya Ohkita, Ryoma Morigaki, Hideo Mure, Yasuhisa Kanematsu, 宮本亮介, Shinji Nagahiro, Ryuji Kaji, Satoshi Goto, 亘雄也, 谷口秀和, 夫敬憲 and 中川義信 : 脳性麻痺に合併した全身性ジストニアに対し脳深部刺激術を施行した1例, 第55回日本定位・機能神経外科学会, Jan. 2016.
46.	Hideo Mure, Ryoma Morigaki, Shinya Ohkita, 小泉英期, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : ジストニアに対するDBS-淡蒼球刺激と視床刺激の併用-, 第55回日本定位・機能神経外科学会, Jan. 2016.
47.	Ryoma Morigaki, 宮本亮介, Shinya Ohkita, Yoshifumi Mizobuchi, Hideo Mure, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : Distribution patterns and functional roles of nuclear factor kappa b in the mouse striatum, 第55回日本定位・機能神経外科学会, Jan. 2016.
48.	Ryoma Morigaki, Satoshi Goto and Ryuji Kaji : Neuropathology of X-linked dystonia parkinsonism, Clinical Neurology, Vol.56, s111, 2016.
49.	Ryoma Morigaki, Shinya Ohkita, Hideo Mure, Yoshifumi Mizobuchi, Satoshi Goto, Ryuji Kaji and Shinji Nagahiro : Nuclear factor kappa bはマウス脳線条体においてドパミンシグナル支配下に機能する, 一般社団法人日本脳神経外科学会第74回学術総会, Oct. 2015.
50.	Hideo Mure, Ryoma Morigaki, Shinya Ohkita, Ryuji Kaji, Wataru Sako, Satoshi Goto and Shinji Nagahiro : Meige症候群に対する両側淡蒼球内節刺激術, 一般社団法人日本脳神経外科学会第74回学術総会, Oct. 2015.
51.	Ryoma Morigaki, Shinya Ohkita, Yoshifumi Mizobuchi, Hideo Mure, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : マウス脳線条体におけるNuclear factor kappa bの機能的分子としての可能性, 第16回日本分子脳神経外科学会, Aug. 2015.
52.	Toshitaka Kawarai, Ryosuke Miyamoto, Tamura Asako, Takashi Abe, Funakoshi Yasuhiro, Orlacchio Antonio, Oki Ryosuke, Hideo Mure, Ryoma Morigaki, Satoshi Goto, Yuishin Izumi, Naito Hiroshi, Tomimoto Hidekazu and Ryuji Kaji : Germline mosaicism of TUBB4A mutation causes dystonia in two siblings., 56th Annual Meeting of the Japanese Society of Neurology, May 2015.
53.	Shinya Ohkita, Ryoma Morigaki, Hideo Mure, 松田拓, Shinji Nagahiro, Satoshi Goto and Ryuji Kaji : Hypomyelination with atrophy of the basal ganglia and cerebellumに対し脳深部刺激術を施行した1例, 第54回日本定位・機能神経外科学会, Jan. 2015.
54.	Hideo Mure, Shinya Ohkita, Shinji Nagahiro, Ryoma Morigaki, Satoshi Goto, Wataru Sako and Ryuji Kaji : Meige症候群に対するGPi-DBS, 第54回日本定位・機能神経外科学会, Jan. 2015.
55.	山村行生, Jiro Kasahara, Ryoma Morigaki and Satoshi Goto : イマチニブのパーキンソン病治療薬としての可能性, 第53回日本薬学会中国四国支部学術大会, Nov. 2014.
56.	Hideo Mure, Ryoma Morigaki, Shinya Ohkita, Shinji Nagahiro, Kazuhito Matsuzaki and Satoshi Goto : ジストニアに対するDBS-淡蒼球刺激と視床刺激の併用-, 第73回日本脳神経外科学会学術総会, Oct. 2014.
57.	田邉彬恵, 山村行生, Jiro Kasahara, Ryoma Morigaki, Ryuji Kaji and Satoshi Goto : MPTPマウスモデルにおける線条体c-Ablチロシンキナーゼを標的としたパーキンソン病治療研究, 第18回活性アミンに関するワークショップ, Aug. 2014.
58.	Jiro Kasahara, 山村行生, 田邉彬恵, Ryoma Morigaki, Ryuji Kaji and Satoshi Goto : MPTP誘発パーキンソン病モデルマウスにおけるc-Abl阻害薬の薬効評価, 第21回カテコールアミンと神経疾患研究会, Apr. 2014.
59.	Nobuaki Yamamoto, Yuka Terasawa, Koji Fujita, Yuishin Izumi, Ryuji Kaji, Ryoma Morigaki, Yoshiteru Tada, Junichiro Satomi and Shinji Nagahiro : 急性期虚血性脳卒中患者のT2*強調画像所見とその変化, 2014年脳卒中学会総会, Mar. 2014.
60.	山本伸昭, Yuka Terasawa, Koji Fujita, Yuishin Izumi, Ryuji Kaji, Ryoma Morigaki, Yoshiteru Tada, Junichiro Satomi and Shinji Nagahiro : 急性期虚血性脳卒中患者のT2*強調画像所見とその変化, 第39回日本脳卒中学会総会, Mar. 2014.
61.	山本伸昭, Yuka Terasawa, Koji Fujita, Yuishin Izumi, Ryuji Kaji, Ryoma Morigaki, Junichiro Satomi, Shinji Nagahiro and Masafumi Harada : 主幹動脈閉塞に伴う虚血性脳卒中における3T-MR T2*-weighted image所見とその変化, 第16回徳島脳卒中研究会, Feb. 2014.
62.	大北真哉, Hideo Mure, Yoshifumi Mizobuchi, Shinji Nagahiro, Ryoma Morigaki, Satoshi Goto, 宮本亮介, 山本伸昭 and Ryuji Kaji : 高インスリン血性高アンモニア血性症候群に合併した全身性ジストニアに対し，脳深部刺激術を施行した1例, 第53回日本定位・機能神経外科学会, Feb. 2014.
63.	Ryoma Morigaki, 小泉英貴, Hideo Mure, 大北真哉, Yoshifumi Mizobuchi, Shinji Nagahiro, Ryuji Kaji, Satoshi Goto and Toshitaka Kawarai : X-linked dystonia-parkinsonismのニューロペプタイドYシステム, 第53回日本定位・機能神経外科学会, Feb. 2014.
64.	Hideo Mure, Ryoma Morigaki, 大北真哉, Shinji Nagahiro, Satoshi Goto, 小泉英貴 and Ryuji Kaji : ジストニックストームにおける治療法の検討-4例の自験例と文献的考察-, 第53回日本定位・機能神経外科学会, Feb. 2014.
65.	山村行生, Ryoma Morigaki, Jiro Kasahara, 横山宏典, 田邊彬恵, Shinya Ohkita, 小泉英貴, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : ドーパミンシグナルはマウス線条体サイクリン依存性キナーゼ5 (Cdk5) のチロシン15残基リン酸化を抑制的に制御する, 第17回活性アミンに関するワークショップ, Aug. 2013.
66.	山村行生, Ryoma Morigaki, Jiro Kasahara, 横山宏典, 田邊彬恵, Shinya Ohkita, 小泉英貴, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : ドーパミンシグナルはマウス線条体サイクリン依存性キナーゼ5 (Cdk5) のチロシン15残基リン酸化を抑制的に制御する, Neuro2013, Jun. 2013.
67.	山村行生, Ryoma Morigaki, Jiro Kasahara, 横山宏典, 田邊彬恵, Shinya Ohkita, 小泉英貴, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : ドーパミンシグナルはマウス線条体サイクリン依存性キナーゼ5 (Cdk5) のチロシン15残基リン酸化を抑制的に制御する, 第20回カテコールアミンと神経疾患研究会, Apr. 2013.
68.	Ryoma Morigaki, Masahito Nakataki, Junichi Iga, Toshitaka Kawarai, Hideo Mure, Yoshifumi Mizobuchi, 大北真哉, Tetsuro Ohmori, Shinji Nagahiro, Satoshi Goto and Ryuji Kaji : X-linked dystonia-parkinsonismのうつ症状, 第52回日本定位・機能神経外科学会, Jan. 2013.
69.	Hideo Mure, Ryoma Morigaki, 大北真哉, Satoshi Goto, Shinji Nagahiro, 小泉英貴, Toshitaka Kawarai and Ryuji Kaji : 両側視床Vo核刺激が奏功したDYT6の一例, 第52回日本定位・機能神経外科学会, Jan. 2013.
70.	Toshitaka Kawarai, Mitsuya Morita, Ryoma Morigaki, Koji Fujita, Hiroyuki Nodera, Yuishin Izumi, Satoshi Goto, Imaharu Nakano and Ryuji Kaji : Pathomechanisms of motor neuron death by mutant TFG., Clinical Neurology, Vol.23, No.11, 1199, 2013. (Summary) Mutations in TFG gene have been demonstrated in hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P) and hereditary spastic paraplegia (HSP). A broad spectrum of TFG pathology is suspected in motor neuron diseases including amyotrophic lateral sclerosis (ALS). We performed mutation screening of TFG gene in ALS cases and evaluated the biological functions of mutant TFG by expression experiment in cultured cells. Two missense mutations associated with sporadic ALS were discovered. Mislocalization of ALS-related proteins, including TDP-43 and optineurin, was demonstrated. These results indicate that mistrafficking of ALS-related proteins by mutant TFG might be a biological cascade leading to motor neuron death. (Keyword) Humans / Mutation, Missense / Proteins / Spastic Paraplegia, Hereditary (Link to Publication Site) ● Publication site (DOI): 10.5692/clinicalneurol.53.1199 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 24291928 ● Summary page in Scopus @ Elsevier: 2-s2.0-84891811182 (DOI: 10.5692/clinicalneurol.53.1199, PubMed: 24291928, Elsevier: Scopus)
71.	佐光亘, Nagako Murase, 溝渕圭史, Ryoma Morigaki, Kazuhito Matsuzaki, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : ジストニア Focal hand dystoniaに対する視床Vo-complex破壊術と淡蒼球刺激術, Functional Neurosurgery, Vol.49, No.1, 98-99, Oct. 2010. (Keyword) ジストニア(治療,外科的療法); 筋収縮; 淡蒼球; 手; 定位脳手術; 脳深部刺激 / 視床破壊術 / ヒト; 中年(45∼64); 男
72.	山本伸昭, Yuka Terasawa, Koji Fujita, Ryoma Morigaki, Junichiro Satomi, Ryuji Kaji and Shinji Nagahiro : 3T MRI T2強調画像におけるischemic vessel signsの検討, 第39回日本脳卒中の外科学会, Apr. 2010.
73.	Junichiro Satomi, Ryoma Morigaki, Kohhei Nakajima, Kenji Yagi and Kyoko Nishi : 大型内頚動脈瘤に対するhigh flow bypass及び頭蓋内親動脈コイル塞栓併用療法の中長期成績, 第39回日本脳卒中の外科学会, Apr. 2010.
74.	北村弥生, Takuya Seike, Ichiro Hashimoto, Hideki Nakanishi, Ryoma Morigaki and Teruyoshi Kageji : 頭蓋骨に発生した動脈瘤様骨嚢腫と考えられた1例, 頭蓋骨に発生した動脈瘤様骨嚢腫と考えられた1例, Feb. 2010.
75.	Ryoma Morigaki, Yoshifumi Mizobuchi, Shinji Nagahiro, 佐光亘, Ryuji Kaji, Satoshi Goto, Masaaki Uno, Shunji Matsubara, Koichi Satoh and Atsuhiko Suzue : 脳血管障害による不随意運動の3症例, 第49回日本定位・機能神経外科学会, Jan. 2010.
76.	Wataru Sako, Nagako Murase, 溝渕圭史, Ryoma Morigaki, Kazuhito Matsuzaki, Shinji Nagahiro, Ryuji Kaji and Satoshi Goto : ジストニア Meige症候群に対する両側淡蒼球刺激術, Functional Neurosurgery, Vol.49, No.1, 94-95, 2010. (Keyword) Meige症候群(合併症,治療); ジストニア(病因,治療); MRI; 淡蒼球(画像診断); 発声障害(病因,治療); *脳深部刺激 / ヒト; 成人(19∼44); 中年(45∼64); 男; 女
77.	Yoshiteru Tada, Ryoma Morigaki, Kenji Shimada, Atsuhiko Suzue, Kyoko Nishi, Masaaki Uno and Shinji Nagahiro : 急性期STA-MCA anastomosisの検討, 第36回日本脳卒中の外科学会, Mar. 2007.

Et cetera, Workshop:

1.	Ryoma Morigaki : パーキンソン病に対する薬物治療と外科的治療, 第287回名西郡・徳島西医師会学術講演会, Sep. 2020.
2.	Taku Matsuda, Hiroshi Kagusa, 梅村公子, Nori Sato, Ryoma Morigaki, Hideo Mure, Yasuhisa Kanematsu, Yuki Matsumoto, Masafumi Harada, Shinsuke Katoh and Yasushi Takagi : ロボットスーツHALを用いた脳卒中急性期リハビリテーションの当院での取り組み, 第8回日本脳神経HAL研究会, Feb. 2020.
3.	Ryoma Morigaki, Hideo Mure, Shinya Ohkita, 小山広士, Ryosuke Miyamoto, Ryuji Kaji and Satoshi Goto : 心因性ジストニアは器質性ジストニアと同じスペクトラムの障害か?, 第2回中四国機能神経外科談話会, Apr. 2017.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

ふたつの異なるモデルによるジストニア発症機序と治療ターゲットの解明 (Project/Area Number: 23K08523 )
ジストニア新規遺伝子機能の解明 (Project/Area Number: 23K06929 )
Development of a new therapy for dystonia targeting the striatal striosome compartment (Project/Area Number: 20K17932 )
Identifying therapeutic targets for dystonia (Project/Area Number: 20K07904 )
Development of new surgical therapies for l-dopa induced dyskinesia targeting striatal striosome comparment (Project/Area Number: 17K10899 )
Development of a new therapeutic strategy for L-DOPA-induced dyskinesia by targeting striosome functions(Fostering Joint International Research) (Project/Area Number: 16KK0182 )
Disease- and Deep Brain Stimulation-Related Metabolic Networks using FDG-PET in Movement disorders (Project/Area Number: 16K10788 )
Development of a new therapy for L-dopa-induced dyskinesia in Parkinson's disease targeting nuclear factor kappa b (Project/Area Number: 26461272 )
Experimental study on functional pathology of dystonia (Project/Area Number: 26430054 )
Molecular mechanisms underlying the rupture of cerebral aneurysms and the pharmacological regulation (Project/Area Number: 24390344 )
Search by Researcher Number (70710565)

Designated Professor : Morigaki, Ryoma

Research

Field of Study

Subject of Study

Book / Paper

Book:

Academic Paper (Judged Full Paper):

Academic Paper (Unrefereed Paper):

Academic Letter:

Review, Commentary:

Proceeding of International Conference:

Proceeding of Domestic Conference:

Et cetera, Workshop:

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)